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ABSTACT
Amblyopia is the most common visual disorder in children and is potentially curable if
detected early and treated properly in the first few years of life. Amblyopia is the leading cause
of monocular vision loss in children (Bradfield, 2013). It is a developmental neuroplasticity which
derives from birth causing structural and functional changes in the eye and brain. With this
structural and functional disruption, visual blur occurs due to refractive amblyopia, strabismic
amblyopia, cataracts (form-deprivation amblyopia), or a combination of any of these (Solebo,
Cumberland, & Rahi, 2015). Refractive errors related to amblyopia can also occur. The purpose
of this evidence-based practice project was to determine if screening a pediatric population
ages 9 months, 24 months, 36 months, and 48 months using an automated visual screener
would affect the number of refractive errors detected. The Stetler Model’s stepwise process for
gathering sound evidence was used to guide this evidence-based practice project at a busy
Midwest pediatric clinic. Anyone that failed the screening was referred to ophthalmology for
further testing. Post-intervention group data were collected on patients from the designated age
groups receiving visual screening during a well-child check-up by two designated providers over
a three-month period. Pre-intervention group data were collected from electronic health records
for patients in the same designated age group receiving a well-child check-up by the same two
providers as post-intervention data over a three-month period. Data were analyzed using
Pearson’s Chi-Square Goodness of Fit test in an effort to show the sensitivity and specificity of
the automated visual screener to screen for amblyopic risk factors. Of the total sample size (N =
322), there were 161 in the pre-implementation group and 161 in the post-implementation
group. Results supported the PlusOptix™ S12 vision screener in identifying more refractive
errors than traditional visual exams performed during routine well child check-ups (χ2 = 20.184a,
p < 0.001, 99% CI).
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CHAPTER 1
INTRODUCTION
Background
Amblyopia is the most common visual disorder in children and is potentially curable if
detected early and treated properly in the first few years of life. Amblyopia is the leading cause
of monocular vision loss in children (Bradfield, 2013). According to Bradfield (2013), Amblyopia
“is defined as reduced best-corrected visual acuity caused by abnormal visual development” (p.
348). It is a developmental neuroplasticity which derives from birth and causes structural and
functional changes in the eye and brain. With this structural and functional disruption, visual blur
occurs due to refractive amblyopia, strabismic amblyopia, cataracts (form-deprivation
amblyopia), or a combination of any of these (Solebo, Cumberland, & Rahi, 2015). Refractive
errors related to amblyopia include myopia (nearsightedness), hyperopia (farsightedness), and
astigmatism (abnormal curvature of the cornea). Another serious cause of visual blur and of
great importance to detect as early as possible is retinoblastoma. “Retinoblastoma is the most
common intraocular tumor of childhood and seventh most common pediatric malignancy”
(Hered, 2011, p. 77).
The US Preventive Services Task Force (USPSTF) statement recommends vision
screening at least once between the ages 3 and 5 (2011). The USPSTF also states that
detection and treatment of amblyopia and amblyopic risk factors in children between ages 3 to 5
years of age leads to great improvement of visual acuity (Mu, et al. 2016; USPSTF 2011).
According to the USPSTF there has not been sufficient evidence to assess the benefits or
harms of vision screening earlier than age 3. However, the American Academy of Pediatrics
(AAP) (2003), and American Association of Pediatric Ophthalmology and Strabismus (AAPOS)
(2003), recommend early childhood screenings starting in newborns and performed with every
well child visit thereafter.
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Vision screenings in the very young can be difficult to perform due to unwillingness to
cooperate and lack of verbal skills. Automated visual screeners (AVS) have been shown to be
effective in the very young population as well as those individuals with autism, attention deficit
hyperactivity disorder (ADHD), and other behavioral issues.
AVS were available commercially about two decades ago. Since then AVS have
improved and continue to become popular in pediatric clinics, family practice clinics, as well as
schools for vision screenings. Studies continue to demonstrate the validity of AVS and are
approved by the AAP in use of preschool age children. AVS are quick and easy to use within a
pediatric clinic and can easily be incorporated into a well-child check without adding much time
(Donahue et al., 2013; Peterseim et al., 2015).
When screening and treating for visual disorders at this early age, especially refractive
disorders, partial to full blindness can be prevented and barriers to literacy, social-emotional
development, self-esteem, and higher academics can be eliminated (AAP, AAPOS, 2003;
Halegoua, 2015; Yan et al., 2015).
Statement of the Problem
This evidence-based practice project was to address vision screening among a
preschool population in a pediatric clinic to detect and mitigate long term effects of amblyopic
risk factors. Sources revealed early detection, especially in the preschool years, of vision
abnormalities can result in full recovery of vision and decrease developmental abnormalities of
binocular vision. Early detection may also decrease costs due to decreased medical visits and
treatments. The AAP, AAPOS, American Academy of Ophthalmology (AAO) and American
Association of Certified Orthoptists (AACO) (2003), report children should have a full visual
assessment at the newborn stage and at all subsequent well child examinations following. The
AAP, AAPOS, AAO and AACO (2003) reported in a policy statement, that early detection of
visual abnormalities is vital to help prevent blindness, identify serious disease (including
neurologic disorders) and prevent school performance problems in the future.
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In children, visual impairment can delay learning causing children to be inadequately
prepared to start preschool or kindergarten. It can also reduce quality of life and function due to
blurring of vision. If visual problems are not detected prior to preschool, visual pathways do not
develop properly and irreversible vision loss occurs. Physiological changes within the eye not
only affects learning but can also have long term effects on an individual’s socialization ability
and self-esteem as early childhood is an important time of social and functional development
(AAP, AACO, AAPOS, AAO, 2003; Bradfield, 2013; Forcina et al., 2017; Koning et al., 2013).
Preschool is the age group in greatest need of screening for refractive errors (Bradfield,
2013; Forcina et al., 2017; Koning, et al., 2013). However, this age group can be the most
difficult to screen due to inability to read visual acuity charts, identify picture charts, and lack of
cooperation while being thoroughly examined for refractive disorders. AVS such as the
PlusOptix™ series photoscreeners can quickly scan patients’ eyes and measure binocular
refractive abnormalities, pupil size, ocular alignment and interpupilary distance without using
pupil dilatation or cycloplegia (Terveen, Moser, & Spencer, 2015).
AVS have been shown in many studies to provide practical, fast, and easy vision
screenings. They are easy to use, portable, and provide quick and accurate detection of visual
issues, which can be addressed by the primary care provider (PCP) or referred to pediatric
ophthalmology for further evaluation and treatment. Studies have shown PlusOptix™
photoscreeners to have sensitivity as high as 94.79% and specificity up to 99% depending on
which amblyopic risk factors are being identified (Arnold & Armitage, 2014; Chang et al., 2015;
Singman et al., 2013; Yan et al., 2015). Sensitivity is the ability of the AVS to correctly identify
children with amblyopia or refractive vision disorders and specificity is the ability of the AVS to
correctly identify children without vision abnormalities (Koning et. at., 2013). Arnold and
Armitage (2014) reported the PlusOptix™ series as having sensitivity of 83% and Specificity of
88%. Yan et al. (2015) reported the PlusOptix’s™ sensitivity of 80.6% and specificity of 76.3%
for amblyopia.
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The PlusOptix™ photoscreener is designed to screen for amblyopia risk factors,
refractive error, anisocoria (unequal pupil size), myopia, hyperopia, astigmatism, retinal
abnormalities, and strabismus (eyes are unparalleled) in children starting at age six months
(Chang et al., 2015; PlusOptix, 2017). Vision screening can be performed in any child, including
those with developmental delays and attention disorders, as the only required compliance is a
short fixation on the camera. Fixation on the camera is provoked by a “warble” sound, which
grabs the attention of the child. The PlusOptix™ has been shown in studies to be accurate. It
screens both eyes simultaneously, accommodating the short attention of the child. It measures
pupil sizes and corneal reflexes automatically, compares refraction of both eyes simultaneously,
checks corneal irregularities, checks farsightedness and nearsightedness, and checks
symmetry of eye alignment all within a few seconds. The PlusOptix™ stores data allowing the
provider to review information in chronological order or it can be downloaded to the patient’s
electronic health record (EHR) and then becomes a permanent part of the patient’s chart. A
print out can be made from the vision screener as well and given to parents to take with them
(Bradfield, 2013; Peterseim et al., 2015; Terveen, Moser, & Spencer, 2015; PlusOptix, 2017;
Yan et al., 2015; Yilmaz et al. 2015).
Data from the Literature Supporting Need for the Project
The USPSTF (2011) reported “1 to 5 percent of U.S. preschool aged children have some
sort of visual impairment”. The USPSTF also reported on a population based study in Los
Angeles county California of over 6,000 children; amblyopia was present in 2.6 percent of
Hispanic/Latino children and 1.5 percent black children (USPSTF, 2011). The USPSTF did not
list the age group of these 6,000 children or specific ethnicity. A Cochrane database systematic
review reported the prevalence of amblyopia between 2 and 5 percent in preschool aged
children (Powell & Hatt, 2009).
USPSTF reported finding adequate evidence to report early detection and treatment of
amblyopia and amblyopic risk factors between ages 3 and 5 leads to “improved vision
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outcomes” (USPSTF, 2011, p. 222). USPSTF also concluded “with moderate certainty that
vision screening for children three to five years of age has a moderate net benefit” (USPSTF,
2011, 222).
Bradfield (2013) reported on a meta-analysis of four randomised clinical trials which
evaluated the treatment effect on children based on age of amblyopia treatment. The metaanalysis concluded children treated prior to seven years old, between ages 3 and 7, were more
responsive to treatment compared to those treated after age seven.
A Cochrane database systematic review done by Powell and Hatt (2009) reports no
evidence of randomised controlled trials looking at the impact of early vision screening,
detection, and treatment of amblyopia. Another aspect of Powell and Hatt’s review was to report
evidence of disabilities in those living with uncorrected amblyopia. The evidence cited was
observational studies from children screened. Powell and Hatt concluded there was not enough
evidence from good quality trials at the time to show optimal protocols for vision screening
Studies are starting to surface looking at the effectiveness of AVS at detecting visual
abnormalities in the preschool age. Studies report the effectiveness of screeners by determining
their sensitivity, specificity, (defined previously) and positive predictive value. Positive predictive
value (PPV) is the true positive measure of a diagnostic test, which describes the test function
(Gordis, 2014). PPV helps answer the question of what proportion of individuals that test
positive actually are positive for a disorder or disease (Gordis, 2014). Singman, Matta,
Fairward, and Silbert (2013), reported the PlusOptix™ photoscreener having a sensitivity of
88%, specificity of 87% and a predictive value of 94% in an age group of < 1 year of age to 15
years. Mu et al. (2016) reported the PlusOptix™ photoscreener as having great promise with
sensitivity of 94.79% and specificity of 85% for detection of amblyopia risk factors in a
population of 4 to 7-year old. Arnold and Armitage (2014) reported in their comparative analysis
of four different photoscreeners, the PulseOptix™ screener had 80%-83% sensitivity, and a
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specificity of 85% to 88% with a positive predictive value of 87% in a population of 1 to 12-year
old
The American Academy of Pediatrics issued a news report in December 2015
condoning instrument-based screening as a valid method of screening in very young children
(AAP, 2016). The AAP also reported AVS can detect visual impairments most commonly found
in young children, such as amblyopia, high refractive error, and strabismus (AAP, 2015).
Data from the Clinical Agency Supporting Need for the Project
The facility where the doctor of nursing practice (DNP) project took place was in a large
Midwest community which opened its doors in 1977 to provide clinical and research programs
focusing on childhood disorders such as deafness, and visual impairment. The hospital now
offers a broad range of clinical services including: general pediatric care; inpatient hospital;
surgery center; ear, nose and throat service; orthopaedic; internal medicine; pediatric
gastroenterology; allergy and asthma; pediatric pulmonology; behavioral health; audiological
and ophthalmologic care. The hospital and clinics have kept to their original mission of providing
healing and hope to children and their families with physical and mental illnesses. The hospital
strives to assemble nationally known personnel in research and clinical treatment to provide
state of the art continuum of care
(https://www.boystownhospital.org/AboutUs/aboutUs/Pages/Mission.aspx).
In keeping with the mission, the pediatric clinics aim was to implement earlier visual
screenings in their six general pediatric clinics with the PlusOptix™. By implementing AVS in
each of the six general pediatric clinics, providers were able to obtain more accurate visual
screenings with early detection of visual abnormalities. Providers could then refer patients to
specialists on site as needed for continuity of care.
The pediatric clinics abide by state law in providing comprehensive vision screenings
using the Snellen eye chart and physician eye exam at pre-kindergarten and seventh grade
physicals (Nebraska State Legislature 79, 2013). Visual screenings using the Snellen chart
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were not typically done at other well-child check-ups (WCC) due to patient load, time
constraints, and unwillingness of preschool age children. Provider visual exams were being
done at WCC. However, visual checks with the naked eye cannot pick up all the many different
visual abnormalities without the use of cycloplegia retinoscopy (pupil dilatation). By
implementing use of PlusOptix™ visual screeners, providers were able to perform regular visual
screenings starting at age 9 months, 24 months, 36 months, and 48 months which have been
shown in literature to be of importance for visual screenings.
Purpose of the Evidence-Based Practice Project
Sources show early detection, prior to starting preschool or kindergarten, of visual
abnormalities is of vital importance for early and maximal treatment. This evidence-based
practice (EBP) project was implemented within a general pediatric clinic which serves a wide
range of socioeconomic and ethnic populations in a large Midwest community. The purpose was
to implement automated visual screenings at well-child visits for ages 9 months, 24 months, 36
months, and 48 months to check for amblyopia risk factors and visual abnormalities. Screening
for these age groups prior to the PlusOptix™ were done by the providers visual exam of the
eye. No Snellen Chart testing was done on a regular basis for these age groups.
Compelling Clinical Question/PICOT Question
Would screening pediatric patients within this general pediatric clinic result in early
findings of amblyopia and amblyopia risk factors? This led to the PICOT question: In a pediatric
population aged 9 months, 24 months, 36 months, and 48 months (P), how does early vision
screening using automated photo vision screeners (I) compared to traditional vision screening
techniques (C) affect the number of refractive errors detected (O) within three months (T)?
Significance of the EBP Project
The ultimate goal of this EBP was to compare vision screening results from traditional
provider screening methods to screening results from an AVS, the PlusOptix. This would
compare referral rates between the two groups. Failed screening results from the pre- and post-
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implementation groups would be compared to follow-up ophthalmology results to check for
sensitivity and specificity of screening methods provided during WCC. By implementing and
gathering data on AVS outcomes within these pediatric clinics, the clinics could show sensitivity
and specificity of the PlusOptix, the necessity of having this type of screening tool in each clinic,
and continued need for early vision screenings prior to kindergarten. Collection and aggregation
of data on screenings and referrals benefits individual patients within the clinics as well as the
broader population served in the community by advancing the understanding of early vision
screenings, visual disorders, and treatment.
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CHAPTER 2
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE
In this chapter, an overview of the theoretical framework and EBP model chosen to
guide the DNP project are provided, along with their application, strengths, and limitations.
Sources of relevant evidence are revealed with the hierarchy levels and appraisal information.
Synthesis of critically appraised literature, best practice model recommendation, and how the
best practice model answered the clinical question are discussed.
Theoretical Framework
Overview of Theoretical Framework
Health Promotion Model (HPM) by Nola J. Pender was used as the theoretical
framework to help guide the EBP project. Pender’s HPM was originally published in 1982, it was
revised in 2001 into the Pender Health Promotion Model by Pender, Murdaugh, and Parsons
(George, 2011). The HPM complements other health protection models to enhance health and
well-being. It offers a process to help motivate individuals to participate in positive behaviors to
enhance their health. Pender’s HPM stresses the importance of self-direction, self-regulation,
and perceptions of self-efficacy (George, 2011). The HPM operates from four main
assumptions: Individuals seek to regulate their own behavior; individuals interact with the
environment, transforming themselves and the environment; health providers make up part of
an individuals’ interpersonal environment, which will influence the individual throughout the
lifespan; and self-initiated rearrangement of the person-environment is necessary for behavior
patterns to change.
There are eight theoretical propositions or behaviors within the HPM believed to be
major motivators in individual health-promotion and include: perceived benefits of action,
perceived barriers to action, perceived self-efficacy, activity-related affect, interpersonal
influences, situational influences, commitment to a plan of action, and immediate competing
demands and preferences (Friedman, Bowden, & Jones, 2003; George, 2011). Perceived
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benefits of action come from an individuals’ personal experience either from being directly
involved or observation of a family member or friend. Perceived barriers to action are just that
“perceived” but can have a major impact on decision making. Perceived self-efficacy is related
to one’s own judgement about self, individual skills, and whether an individual can accomplish
the desired behavior. Activity-related affect is the result that a particular behavior or action had
on an individual. The activity-related affect considers the affect before, during, and after the
action. The more positive the subjective feeling has on an individual the greater the feelings of
efficacy. These greater feelings of efficacy can lead to positive affect. Interpersonal influences
are the individual’s own thoughts or beliefs, which may or may not accurately describe a
behavior or situation, and can be influenced by family, friends, or other outside sources.
Situational influences affect a behavior in different situations based on a person’s perceptions of
options available or demanding characteristics of the environment such as: hand washing
requirements in a work place or dress code requirements. Situational behaviors require the
individual to participate in a way they may not normally. Commitment to a plan of action
identifies a strategy for reinforcing or carrying out a behavior which then leads to implementation
of the behavior. Immediate competing demands and preferences refer to alternative behaviors
where the individual has little control such as work or family commitments, whereas competing
preferences are alternative behaviors where the individual has high control such as choosing to
eat ice cream.
The HPM postulates that specific behaviors and cognitions are directly related to
individual health promotion behaviors (Friedman, Bowden, & Jones, 2003; George, 2011). An
individual’s prior behavior as well as inherited and acquired characteristics have great impact on
the individual’s beliefs, affect, and how the individual views health promoting behaviors. An
individual is more likely to engage in behaviors where valued beliefs are enhanced. When an
individual has positive perceptions, believes there are minimal barriers to the action, has
positive feelings about the health behavior, has positive family and peer support, has positive
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role models and available environmental resources the individual tends to commit to a plan of
action. This in turn promotes positive health behavior. The intent of the health promotion plan is
that the individual will realize positive benefits to their health and well-being. The benefits
realized would not just be for the present but benefits which will lead to overall health to last
them a lifetime and be passed down to generations to come (Friedman, Bowden, & Jones,
2003; George, 2011).
Application of Theoretical Framework to EBP Project
Pender’s HPM focuses on individual characteristics, experiences, behavior-specific
cognitions, and one’s affect and behavioral outcomes. The HPM was appropriate for this EBP
project as the clinic location for the project prides itself on health promotion and disease
prevention. Pediatric providers highly recommend routine yearly health maintenance checks
until patients reach 19 years of age or 23 years of age (when they are finished with college).
Well-child checks are gently reinforced by requiring patients to be listed as a new patient if they
have not been seen within the clinic setting by their PCP for two years or longer. Appropriate
appointment times can then be set to allow enough time for a thorough exam to make sure the
individual is healthy and their chart is accurately updated. By requiring individuals to maintain
yearly well-checks, providers are able to catch health issues before they become a major
problem and possibly preventing health problems. Yearly well-checks also allow providers to
stay abreast of chronic health conditions so when there is an acute illness, proper care can be
taken to insure a quick and uncomplicated recovery. The goal of requiring regular exams is to
model and promote positive health behaviors which will influence individuals to commit to for a
lifetime.
New implementation of AVS was one-way the providers could continue to promote
health and disease prevention within their general pediatric clinics. By using the latest
technology of AVS, providers were able to screen at earlier ages for visual errors as well as
provide a more in-depth screening at well-child checks (WCC). Many studies have shown early
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detection, prior to starting preschool or kindergarten, of visual abnormalities is of vital
importance for early and maximal treatment. Visual abnormalities reduce quality of life and
function due to blurring of vision. If visual problems are not detected prior to preschool, visual
pathways do not develop properly and irreversible vision loss occurs (AAP, AACO, AAPOS,
AAO, 2003; AAP, 2016; Bradfield, 2013; Donahue et al., 2013; Terveen, Moser, & Spencer,
2015). The USPSTF reported “1 to 5 percent of U.S. preschool aged children have some sort of
visual impairment” (USPSTF, 2011, p. 2) and Mu et al. (2016), estimate 1.6% to 3.6% of
children in industrialized nations have a preventable visual impairment. Koning et al. (2013)
found in a 7-year cohort of 4624 children with an overall prevalence of amblyopia to be 3.6%.
Pender’s HPM suggests if a family perceives a threat and there are opportunities for
decreasing that threat, such as health screenings, the family will be more likely to act on it
(Friedman, Bowden, & Jones, 2003). By using AVS within the clinic setting during routine WCC,
providers could perform in depth vision screenings to detect problems, a screening the patient
might not have received otherwise. This Midwest hospital and clinics serve a wide
socioeconomic and ethnic population with the majority of them having little to no insurance.
Therefore, many of the patient population does not seek out preventive eye care from an
optometrist or ophthalmologist. The HPM was used to help modify patient behaviors by looking
at modifying factors (demographic variables, sociopsychological variables, structural variables)
to show perceived threats and provide cues to action.
The six major motivators were taken into consideration when using the HPM as a guide
for educating parents and patients for the need of early vision screening. Education was
provided prior to performing AVS screenings from evidence found in the literature which shows
benefits of action (early vision screening). When providing information, parents and patients will
be able to actively own the behavior of early vision screening. Perceived barriers to action, such
as little or no insurance, were addressed by assuring families most insurance companies cover
vision screenings using AVS. Clients were not charged for the screening using the PlusOptix™
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if insurance did not cover it or cover all the cost. Early vision screenings can reduce treatment
length and overall cost, further addressing perceived barriers to screening. This further
influences the six behavioral motivators affecting optimal well-being, personal fulfillment, and
productive living.
Strengths and Limitations of Theoretical Framework for EBP Project
Health promotion and disease prevention should be the primary focus in the health care
setting and needs to be easy to understand in order to change or reinforce positive health
behaviors. The HPM allows for ease of applicability by its simplistic stepwise approach. Its’
holistic focus based in nursing gives it strength by promoting independent practice which
provides health promoting interventions and education to individuals. The HPM can be used by
other disciplines even though it was proposed as a framework for nursing. The HPM was
intended for any individual in any situation other than the illness state. By using the eight
theoretical propositions or variables the model allows for a complete picture of the patient and
progression toward improving health behaviors. However, the many variables within the HPM
also can be a limitation making it difficult to test all of the relationship statements. Without being
able to test all the theoretical propositions or variables at once, one is not able to see how the
variables influence each other or the outcomes of health promotion. Not only is testing all the
variables difficult to do, it may also be difficult for providers to implement all eight variables
within a reasonable time-frame. George (2011) points out another limitation within the HPM. The
spiritual growth component is not considered under personal factors of the HPM. Spiritual
growth is a component often listed and helps in guiding an individual when using other
theoretical models.
Evidence-based Practice Model
Overview of EBP Model
The term “evidence-based practice” (EBP) derives from the definition of “evidence-based
medicine” (EBM) and is defined as: “Evidence based nursing practice is the conscientious,
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explicit, and judicious use of theory-derived, research-based information in making decisions
about care delivery to individuals or groups of patients and in consideration of individual needs
and preferences” (Ingersoll, 2000, p. 152).
The Stetler Model (SM) provides a stepwise process for gathering sound evidence that
can guide safe and effective care or evidence-based practice. The SM uses a prescriptive
approach emphasizing critical thinking as a key role. The SM relies on five steps which include:
preparation, validation, comparative evaluation/decision making, translation/application, and
evaluation (Stetler, 2001).
Preparation entails identifying a need, identifying the environment it involves, organizing,
and initiating evidence research. The SM advises nurses or providers to be very clear during the
preparation phase by emphasizing clarity of purpose along with potential significance of internal
or external factors (organizational goals, imposed deadlines or politics involved with making a
change, etc.). Clarity includes specifics regarding who the stakeholders are, what types of
research or information will be needed to show the need for change, and how the outcomes will
be defined (Ciliska et al., 2011; Stetler, 2001; Young, 2012).
Validation requires combing through a body of evidence to select evidence which best
identifies the need for change. In this second phase of the Stetler model, APN’s and nurses
decide if there is enough credible evidence to support the wanted or needed change to continue
moving forward with the process. The process is done by utilization focused critique and
synopsis (Ciliska et al., 2011; Stetler, 2001; Young, 2012).
Comparative evaluation/decision making involves applying a set of criteria to evidence
collected in the validation phase to further decide what evidence best identifies or supports the
practice change. Comparative evaluation/decision making is where organization of collected
evidence and critical appraisal of evidence collected takes place. Evidence is either labeled not
to use, to use, or to consider use (still being considered until additional information or internal
evidence is gathered) based on strength of the evidence once the critical appraisal is done.
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Final decisions are then made as to whether enough research exists to support the practice
change (Ciliska et al., 2011; Stetler, 2001; Young 2012).
Translation/application requires converting the evidence findings into practice by
disseminating the evidence to those involved and needed in the application process. Then a
plan is put into action. Translating or applying the plan is not always an easy process depending
on the type of change to be made and who is involved. Getting everyone on board is often
difficult. Providers need to carefully consider how information will be distributed to all involved
parties. Young (2012), purports “change is the heart of this phase” (p. 390).
Evaluation then involves assessing the new plan of practice to ensure goals were met,
monitor for any adverse occurrences, if any changes need to be made, and how to continue
providing the new plan of practice (Ciliska et al., 2011; Young, 2012). In the evaluation process
and decisions are made if the new process or clinical practice change can be extended into
other clinic areas. The evaluation process is also a continuous process of internal data
collection, feedback from the users of the clinical practice change in order to obtain continual
improvements.
Application of EBP Model to EBP Project
Previous screening practices at the project site included detailed vision screenings using
the Snellen chart at ages 4 and 5 years prior to beginning kindergarten. Even then, screenings
did not include comprehensive refractive error screenings that typically involve pupil dilatation
known as cycloplegic screening. As mentioned previously in this paper, early visual screenings
for refractive errors is crucial within the early years of life. The project site providers see patients
across a wide range of socioeconomic and ethnic backgrounds, many with little to no insurance
coverage. That being said, many will not see an optometrist or ophthalmologist for preventive
visual screenings. It was hoped that the AVS would provide needed refractive error screenings
to the project site pediatric population.
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Using the (SM), evidence was collected and aimed to show the use of AVS are effective
at screening for refractive visual errors as early as age nine months, as recommended by the
AAP and USPSTF (The American Academy of Pediatrics [AAP], 2015; AAP, 2016; Forcina et
al., 2017; Koning et al., 2013). The American Academy of Pediatrics issued a news report in
December 2015 stating instrument-based screening is a valid method of screening in the very
young children (AAP, 2015; AAP, 2016). The AAP and USPSTF also reported endorsing AVS
as they can detect amblyopia and ocular conditions known to cause amblyopia such as high
refractive errors and strabismus. (AAP, 2015; AAP, 2016). After carefully weighing available
research, the project manager believed there was significant evidence to proceed with the EBP
project.
Careful condensing, organizing, and labeling of evidence gathered during the evidence
phase was done by applying the Critical Appraisal Skills Programme (CASP) tool. After careful
consideration, CASP was decided upon for its reliability, completeness, and its ease of use.
CASP includes a set of eight appraisal tools to evaluate systematic reviews, randomised
controlled trials, cohort studies, case control studies, economic evaluations, diagnostic studies,
qualitative studies and clinical prediction rule (http://www.casp-uk.net/casp-tools-checklists).
Melnyk and Fineout-Overholt’s (2011) Rapid critical appraisal checklist was used to carefully
evaluate the clinical guidelines found while collecting evidence. Enough sound evidence was
collected to move onto the fourth phase of the SM.
Evidence was communicated to all providers and staff who were involved in carrying out
the change in practice through copies of research information collected, power points and
videos provided from PlusOptix™. PlusOptix™ screeners were put in the budget plan in hopes
the clinics would purchase some of the screeners to be tried out within the general pediatric
clinics. Based on evidence provided and one of the clinics provider having previous experience
with using this type of visual screener, budget was approved for purchase of six screeners. One
screener was placed in each of the six general pediatric clinics. Education was provided to each
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provider and clinic staff member who were involved in using the screeners. Education included
information on the devices themselves, as well as policy and procedure for using the
PlusOptix™ within the clinic setting.
Phase five of the Stetler model evaluated expected outcomes stemming from the original
PICOT question: In a pediatric population aged 9 months, 24 months, 36 months, and 48
months, how does early vision screening using automated vision screeners compared to
traditional vision screening techniques affect the number of refractive errors detected within
three months?
Strengths and Limitations of EBP Model for EBP Project
The Stetler Model has a great use within individual practice, emphasizing critical thinking
and decision making. Its five phase step approach aids in the critical thinking and decisionmaking process with ease of use. It allows for synthesis of internal and external evidence in
routine practice which fits well within the general pediatric clinic settings. The systematic
approach aids in critiquing and translation of research findings into clinical practice. By using the
systematic approach of the SM, evidence is substantiated to support the needed clinical change
within the project setting.
The SM is not set up for ease of use as an overall organizational change process but
more for an individual clinic practice change agent. Ciliska et al. (2011) reports overall
organizational change is not as easy application for the SM due to its practitioner focus for
clinical change. The SM guides practitioners in a five-phase approach and how the practitioner
can implement research findings to direct patient care.
Literature Search
Sources Examined for Relevant Evidence
An extensive literature search for relevant and best evidence was conducted using
multiple databases including Cumulative Index of Nursing and Allied Health Literature
(CINAHL), ProQuest Nursing and Allied Health, Johanna Briggs Institute EBP Database, The
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Cochrane Library, Medline with full text, and National Guideline Clearinghouse. A hand search
was also conducted from relevant articles’ references and reviewed for applicability to the EBP
project.
Key words from the PICOT question were used for search terms. A combination of
search terms were tested during this evidence search yielding no results. After combining key
words, implementing Boolean phrases, playing with date limiters, employing the use of
quotations and asterisks a “best search” was reached. The final set of keywords/terms settled
on and yielding the best results in all six databases were: PlusOptix™, Amblyopia, refractive
error, vision screen, and photoscreen (see Table 2.1).
The “best search” yielded 429 relevant sources. Forty-nine were chosen by the project
leader after reading through the summaries for literature review. From the 49, seven were kept
by the project leader based on relevance to the EBP project, evidence level, and inclusion
criteria. Inclusion criteria were the years between 2007 and 2017 and English language for
literature review.
CINAHL yielded 70 sources with four kept for best evidence. ProQuest Nursing and
Allied Health yielded 146 sources using the key terms. The three sources kept from ProQuest
overlapped with Medline and CINAHL. Johanna Briggs Institute yielded eight sources with no
sources kept for best evidence. The Cochrane Library yielded 33 total sources using keywords,
with two sources kept for best evidence. Medline with full text using the final set of search terms
yielded the most sources at 172 for best evidence. Seven sources were kept from Medline.
Three of the sources overlapped with CINAHL and three sources overlapped with ProQuest. No
articles were kept through the hand search process for best evidence.
Articles included in final results pertained to pediatric population ages birth to 5 years,
male and female, need for early vision screening, automated vision screener comparisons to
each other and to traditional cycloplegia retinoscopy, and early screening methods. Final results
included after searching databases listed, key words/terms, inclusion criteria and hand
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searching; ten sources were kept for best evidence including 2 guideline summaries. Ten
sources (including text books) and three guideline summaries were kept for use as background
knowledge in this EBP project.
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Table 2.1
Literature Search Results

Database

CINAHL

ProQuest
Nursing and
Allied Health

Keyword(s)

PlusOptix OR Amblyopia OR
"refractive error*" AND “vision
screen*” OR photoscreen*

PlusOptix OR Amblyopia OR
"refractive error*" AND “vision
screen*” OR photoscreen*

Limiters

Date
Limiters

2007-2017

Results

Relevance/Kept

70

4 (3 overlap with
Medline; 1 overlaps
with ProQuest)

English language

English language

Johanna Briggs
Institute

PlusOptix OR Amblyopia OR
"refractive error*" AND “vision
screen*” OR photoscreen*

Cochrane

PlusOptix OR Amblyopia OR
"refractive error*" AND “vision
screen*” OR photoscreen*

English language

Medline with
Full text

PlusOptix OR Amblyopia OR
"refractive error*" AND “vision
screen*” OR photoscreen*

English Language, Word in major
subject heading (MJ)

English language

21

146

3 (2 overlap with
Medline; 1 overlaps
with CINAHL)

2007-2017

8

0

2007-2017

33

2 (1 from Cochrane
review; 1 from trials)

2007-2017

2007-2017

172

7 (3 overlap from
CINAHL; 3 overlaps
with ProQuest)
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Levels of Evidence
Critical appraisal of evidence is necessary to obtain evidence that is valid, reliable, and
applicable to support the clinical change. In order to critically appraise evidence, sources must
be ranked on a hierarchy scale. Sources of evidence for this EBP project were evaluated and
categorized using the “Hierarchy of Evidence for Intervention/Treatment Questions” also known
as “Pyramid of Evidence” (Melnyk & Fineout-Overholt, 2011; Russel, 2012) (see Table 2.2). A
total of seven sources were kept and ranked using the Pyramid of Evidence. Hierarchy of
evidence is a rating scale used to grade evidence pertaining to the topic at hand in order to
guide the investigator to the most reliable information. There are seven essential levels to the
pyramid of evidence, Melnyk and Fineout-Overholt mentions (2011). The highest of the rankings
start at the top of the pyramid as Level I and moves down towards Level VII. Level I include
systematic reviews and meta-analysis of all relevant randomised controlled trial. These are
considered the best evidence for guiding practice. Level II is evidence obtained from welldesigned randomised controlled trials. Level III evidence is obtained from well-designed nonrandomised controlled trials. Level IV is evidence from case-control and cohort studies. Level V
includes systematic reviews or descriptive and qualitative studies. Level VI are sources of
evidence from single descriptive or qualitative studies. Level VII consists of evidence from
authoritative opinions and/or reports from expert committees such as guidelines from USPSTF
or AAP (Melnyk & Fineout-Overholt, 2011; Russel, 2012). By placing the available research or
information gathered into a hierarchy pyramid, as Melnyk and Fineout-Overholt recommends, it
allows for clarity in evaluation of the evidence as it pertains to the PICOT question being asked.
The CASP tool was used to test the strength of the evidence for validity, importance of
results of the evidence, and if the results of the evidence are useful (http://www.caspuk.net/checklists). CASP provides a set of eight questionnaires to be used when reading
research to help grade each level of evidence for strength, results, and usefulness. Once the
evidence has been found valid, clinical significance of the results needs to be determined
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looking at confidence intervals, p values, and sensitivity analysis. Evidence is then given an
appraisal rating based on quality of the study performed. CASP does not provide this rating
scale with its questionnaires for each type of study. It is up to the clinician to apply a rating
scale. Appraisal rankings in this EBP project were labeled: high, medium, and low. If clinical
significance is found, then determination needs to be made how the evidence applies to the
individual clinical practice change. Critical appraisal of evidence helps provide transparency to
the evidence found and helps examine sources for bias.
There are four main types of biases: selection, detection, attrition, and performance.
Selection bias is controlled by randomization, concealment of population, treatments, and
results. Detection bias is controlled by researchers and all participants involved, including data
collectors and population participants being masked to outcomes, and grouping of participants.
Attrition bias looks at how participants lost to fall out are accounted for. Performance bias is
controlled by masking of participants and researchers to group allocation (Powell & Hatt, 2009).
Appraisal of Relevant Evidence
Level I Evidence
A systematic review by Powell and Hatt (2009) was retrieved from the Cochrane
Database of Systematic Reviews. The purpose of the review was to look at randomised
controlled trials and cluster-randomised trials to evaluate vision screening and its results on
amblyopia compared to non-screened pediatric population. Powell and Hatt (2009) assessed
study summaries independently then obtained relevant full text articles. However, they
discovered there were no studies on screened versus unscreened children to review. The
studies were all observational.
One-thousand forty-nine sources were obtained, three sources were kept for the
systematic review. Powell and Hatt (2009) found that despite the large amount of literature
available regarding pediatric vision screenings, they were not able to find research trials
designed to compare prevalence of amblyopia in screened versus non-screened children. They
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concluded there is no optimal protocol for carrying out screening and there is a clear need for
more reliable research on the effectiveness of vision screening programs. Powell and Hatt
suggested the impact of screening for amblyopia is to detect other vision abnormalities such as
refractive errors. Recommendations were made for more evidence regarding living with
uncorrected amblyopia. Appraisal quality given to this systematic review is high as the review
clearly addressed the focused questions, best studies were used, three databases were used to
find sources relevant to focused question, and rigor was used to assess quality of studies found.
Overall results were clear; however, specific statistics were not indicated with confidence
intervals, odds ratio, or other statistical data.
The Oregon Evidence-based Practice Center (EPC) conducted a systematic review of
randomised trials and controlled observational studies searching from 1950 to July 2009
(Oregon Evidence-based Practice Center [EPC], 2011). The EPC looked to answer eight key
questions:


Is vision screening in children ages 1-5 years associated with improved health
outcomes?



Does effectiveness of vision screening in children ages 1-5 years vary in different
age groups?



What is the accuracy and reliability of risk factor assessment for identifying
children ages 1-5 years at increased risk for vision impairment?



What is the accuracy of screening tests for vision impairment in children ages 1-5
years?



Does accuracy of screening tests for vision impairment vary in different age
groups in children ages 1-5 years?



What are the harms of vision screening in children ages 1-5 years?



What is the effectiveness of treatment for vision impairment in children ages 1-5
years?

24

SCREENING AMBLYOPIC FACTORS 25


What are the harms of treatment in children ages 1-5 years at increased risk for
vision impairment or vision disorder? (Oregon Evidence-based Practice Center
[EPC], 2011).

To answer question one, the EPC could not find randomised trials evaluating outcomes
of vision screenings in children ages 1-5 years compared to children without having vision
screenings. However, the EPC did find a large randomised trial, felt to be of fair quality, nested
within a population-based cohort study. The randomised trial showed decreased likelihood of
amblyopia at age 7.5 years after having repeated orthoptists screenings between ages 8
months to 37 months. No randomised trials were found comparing outcomes of preschool vision
screening in different age groups to answer question 1a. No difference between vision
screenings were reported in one of the cohort studies looking at vision screenings at ages 2 and
4 years compared to screenings prior to age 2 years. The EPC found no studies evaluating the
accuracy or reliability to identify children at higher risk based on demographic or clinical
features, answering question 2.
Question three by the EPC revealed thirty-one studies looking at the accuracy of various
preschool vision screening tests compared to standard cycloplegic refraction screening. None of
the studies were recorded as being “good-quality”. Overall conclusion by the EPC was all
screening tests showed accuracy estimates suggesting usefulness for identifying children ages
1-5 years at higher risk for amblyopic risk factors.
Question four was difficult for the EPC to answer as evidence related to comparing
accuracy of screening tests for vision impairment in different age groups from ages 1 year to 5
years was limited. Four of the studies reviewed found no difference among the various age
groups. Four studies found lower testability using certain screening methods in ages 1 year to 3
years compared to children ages 4 years to 5 years. Studies were limited on the harms of vision
screening in children ages 1 to 5 years. A large cohort reported a fifty percent reduction in odds
of being bullied at age 7.5 years of age in children who did receive vision screening compared
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to those children who did not receive vision screening. No study looked at harms to
unnecessary treatment or use of corrective lenses for amblyopia on long-term vision or
functional outcomes.
Question five was addressed with one good quality trial showing patching of one eye
plus eyeglasses and eyeglasses alone were more effective than no treatment at all. Two other
studies reviewed showed small average improvement in visual acuity in children with amblyopia
after a five to twelve-week follow-up. No studies were found that looked at effects of treatment
compared with no treatment on school performance.
Five studies reviewed showed some increased risk for temporary vision loss in the nonamblyopic eye when the amblyopic eye was treated, helping to answer question 6 of the EPC’s
review questions. No risk was found in three trials for increased risk for visual acuity loss
between patching and using atropine regimens for treatment.
After attempting to answer all six questions posed by the EPC, the overall conclusion by
the EPC was that preschool vision screenings are effective for diagnosis and treating visual
disturbances, mainly refractive errors, compared to no early screenings in preventing long term
problems. Appraisal score given to this systematic review is high. The EPC clearly addressed
all six of the focused questions, a large assortment of study trials were included. Detailed
information was given as to the rigor of studies included with overall results of each study
reviewed listed in the report. All important outcomes were considered including population
setting. The EPC did report all study trials reviewed were studies done within community
settings or ophthalmology setting and this could be a limiting factor.
Level II Evidence
Arnold and Armitage (2014) performed a random controlled trial on 108 children ages 1
year to 12 years in an Alaska Pediatric eye practice. The purpose was to compare four different
visual photoscreeners, the GoCheckKids™ (www.gocheckkids.com), PlusOptix S09™
(https://PlusOptix.com), SPOT™ (www.welchallyn.com), and iScreen
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3000™(www.iScreen.com). GoCheckKids™ is software that can be uploaded to Apple products
such as; iPhone® and iPod touch®. Images of eyes are taken then uploaded to the
GoCheckKids™ website for interpretation. PlusOptix S09™ is an infrared photoscreener which
has the individual fixate on a light emitting from camera. Images are taken of eyes/pupils then
interpreted by PlusOptix™ software for refractive error, ocular alignment, and pupil size.
SPOT™ is a hand-held photoscreener which takes images of the eyes/pupils and makes
estimation of pupil size, interpupilary distance, ocular alignment, and refractive error. The
SPOT™ has a WIFI remote printer so readings can be printed. iScreen™ is also a hand-held
photoscreener which has a keyboard, monitor, and port for data import or export. iScreen™
operates with a red laser beam that is aimed at the eyebrows, it then captures an image of the
pupils. Images can be sent to an iScreen™ interpretation database immediately or stored and
uploaded some later time once multiple screenings have been completed (Arnold & Armitage,
2014).
Each participate was screened with each of the four screeners in random order by
orthoptist and pediatric ophthalmologist with results masked to the participant and the screeners
until all screenings were completed (Arnold & Armitage, 2014). Validation statistics were
completed using a 2X3 table to show sensitivity and specificity of each photoscreener used.
Sensitivity of all four photoscreeners averaged 80%. Specificity of all four photoscreeners
averaged 88%. Arnold and Armitage reported all four screeners had advantages and
disadvantages. The PlusOptix™ was not cordless and required connection to a computer with a
monitor by a cable; therefore, it was less portable than other screeners. It also had more
difficulty yielding results for children with high refractive errors. However, the PlusOptix™ was
able to report refractive error, ocular alignment, pupil size, and interpupilary distance as well as
having good validation and calibration calculations due to revisions of prior models. iScreen’s™
central interpretation location leading to a longer wait time for results and refractive error was
not estimated. iScreen™ was reported as being easy and quick to use with “excellent ABCD
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statistics and ir-sensitivity” (Arnold & Armitage, 2014, pg. 51) the terms chosen by Arnold and
Armitage to indicate inconclusive in the denominator of analysis (ABCD) and inconclusive
referrals (ir-sensitivity).
The SPOT™ took a little longer with a visual fixation time of 2 seconds or greater.
However, the SPOT™ was reported as having “extensive eye examination” (Arnold & Armitage,
2014) consisting of pupil size, interpupilary distance, refractive error, and an estimate of ocular
alignment. GoCheckKids™ required steadiness by the screener in order to produce proper
image quality.
GoCheckKids™ had no stimulus light on the phone for the individual to fixate to assure
proper image. Screening with the GoCheckKids™ looks at ocular alignment and red reflex
dimensions. Images need to be uploaded for interpretation and are not readily available for
viewing. GoCheckKids™ was applauded for its simplicity for interfacing with the iPhone®.
Conclusion of all four photoscreeners was that all are good for accuracy of vision screening and
valuable in identifying treatable vision disorders early enough for therapy to be successful.
The appraisal score given to this random controlled trial was medium. The interpreter of
the visual images was not completely blinded to patient identities. Researchers were not as
accustomed to the GoCheckKids™ screening tool compared to the PlusOptix™, iScreen™, and
SPOT™, as it was a newly acquired tool for them. Arnold and Armitage (2014) also reported the
individuals screened were attending a pediatric eye clinic. Therefore, the population studied
may not have been a good representation of the population typically seen in a general pediatric
clinic within the community. Statistical outcomes were given but there were no in-depth
discussions regarding statistical analysis used. Good information and sensitivities and
specificities were provided regarding each photoscreener.
Level III Evidence
Mu et al. (2016) performed a non-randomised control trial to compare visual screening
with SPOT™ photoscreener to traditional cycloplegia retinoscopy. Children (N = 155), ages 4-7
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years, attending a specialty eye clinic at Tianjin University hospital in Helsinki for eye check-ups
were screened. The children were screened first with a complete ophthalmologic examination,
then photo screening using the SPOT™ screener, followed by cycloplegia and retinoscopy.
Optometrists were masked from results using the SPOT™ screener as well as the individual
being screened. Measurements were unobtainable from 13 of the original 168 children due to
fear, and others previously diagnosed with hyperopia, esotropia, congenital ptosis, congenital
nystagmus, and congenital cataracts. Successful screening was done on 155 children, 71 girls
and 84 boys. Twenty--six children had amblyopia, 115 had amblyopic risk factors, 65 had
hyperopia, 28 had myopia, 59 had astigmatism, 32 had anisometropia, and 37 had strabismus.
Wilcoxon signed rank test showed the difference between SPOT™ photoscreener and
cycloplegic retinoscopy was not statistically significant at p < 0.01 indicating a weak correlation.
The Bland-Altman plot test showed moderate agreement between the SPOT™ photoscreener
and cycloplegic retinoscopy. The SPOT™ showed high sensitivity of 94.79% and specificity of
85% in detecting amblyopia risk factors based on the AAPOS 2013 guideline. Mu et al.
concluded the SPOT™ showed moderate agreement with the results of cycloplegia retinoscopy
and detecting amblyopic risk factors was satisfactory but could be further improved with
optimizing screening criteria.
Critical appraisal score was high. The aim of the research was made clear. Ethical and
bias issues were addressed and clearly laid out in this source. Statistical analysis was
discussed in detail to show how sensitivity and specificity was reached. One limitation was the
population screened had a high prevalence of amblyopia risk factors compared to community
population or school based samples from other studies.
Singman et al. (2013) conducted a retrospective medical records review on an autistic
pediatric population, ages <1 year to 15 years with the average age being 6 years, in an
ophthalmology practice. Children (n = 4) were identified as having autism in the retrospective
medical records review. The children were seen between January 1, 2001 and April 12, 2012.

29

SCREENING AMBLYOPIC FACTORS 30
Twenty-five of the forty-eight children had undilated PlusOptix™ photo screenings done with
their clinical exam during the times listed and were chosen to be analyzed. The chosen
population was tested two times with the PlusOptix™. The goal of the review was to compare
reliability of the PlusOptix™ to traditional pediatric vision screenings in a pediatric population
with autism. The PlusOptix™ does not use a flash, which can sometimes upset individuals with
autism. It does use a chirp sound that can be turned off if the child has difficulty with noises. The
PlusOptix™ was shown to be easy to use with rapidly available vision screening results. Results
of double testing with the PlusOptix™ revealed 17 (68%) children had amblyopia risk factors
with both testing’s. The PlusOptix™ was found to have a sensitivity of 88%, specificity of 87%,
positive predictive value of 94%, and negative predictive value of 78%. Singman et al.
concluded that it was difficult to get reliable screening results in children with autism. When
using the PlusOptix™ providers/clinicians can obtain a quick, reliable vision screening result in
individuals with autism and other disorders where attention span and focus is a hurdle.
Low level critical appraisal ranking was given to Singman et al. (2013). The aim of the
research was clearly stated and qualitative methodology was appropriate to address the aims of
the research. Data were gathered in a way to address the research issue. However, biases,
limitations, and ethical issues were not discussed. There was no in-depth discussion on findings
and how it related to other studies in the literature.
Yan et al. (2015) performed a controlled trial without randomization to assess the
accuracy of PlusOptix A09™ photoscreener in detecting amblyopia risk factors in children. Onehundred-seventy-eight children ages 2 years to 14 years attending an ophthalmology clinic at
Provincial Hospital in Shandon Helsinki were chosen for the controlled trial. Comprehensive
ophthalmic exams were done in the following order: PlusOptix A09™ screening; orthoptic exam
with prism alternative and cover test; anterior segment assessment using slit lamp; fundus
exam; and then a cycloplegic retinoscopy exam. Each child was tested two times with the
PlusOptix™. The Optometrists performing cycloplegic retinoscopy were masked to the
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measurements obtained from the PlusOptix™. Data analysis to compare refractive
measurements between PlusOptix™ and cycloplegic retinoscopy were calculated. Descriptive
data were presented as mean, standard deviation, and frequency. Paired t-test and curve
estimation regression analysis were performed to assess differences and quantitative
relationships. The Bland-Altman plot test was used to measure agreements between the
PlusOptix™ and retinoscopy. ROC curve was used for cut-off points. Pearson’s correlation
coefficient was used to confirm consistency of the two measurements from the PlusOptix™.
Results showed 86 (48.3%) children diagnosed with amblyopia (Yan et al., 2015). Sixtythree (35.4%) children were diagnosed with strabismus. The PlusOptix A09™ showed
sensitivity for detecting refractive amblyopia risk factors of 80.6%. Specificity of the PlusOptix
A09™ for detecting amblyopia risk factors was 76.3%. After applying ROC curve, the overall
sensitivity of the PlusOptix A09™ in detecting refractive amblyopia was 94.9% and specificity for
detecting refractive amblyopia was 63.2%. Spherical equivalent showed significant difference
between the PlusOptix A09™ screening results and the cycloplegic retinoscopy screening
results with p = 0.00. Paired t-test showed p = 0.14 for mean cylinder power value (Jackson
cross cylinder at axis 00) and p = 0.26 (Jackson cross cylinder at axis 450). The Bland-Altman
plots showed agreement between the PlusOptix A09™ and cycloplegic retinoscopy for spherical
equivalent and Jackson cross cylinder power values at 450 and 00. Consistency measurements
from PlusOptix A09™ and cycloplegic retinoscopy confirmed with Pearson’s correlation
coefficient, r = 0.95, p = 0.00.
Conclusion by Yan et al. (2015) showed the PlusOptix A09™ is useful in large scale
screenings for refractive errors but may not be suitable for large scale strabismus screenings. It
does not need connection to a computer using cords which made it easily portable as well as
providing faster data acquisition. It was also user and patient friendly. The critical appraisal
score given to the Yan et al. study was high. Yan et al. clearly stated the aims of the research
with appropriate methodologies applied. Recruitment strategy was clearly stated with any
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exclusions to the study listed. The researchers clearly reported data collection and
testing/screenings performed. There could be potential bias in this study related to the
population chosen as it was individuals already attending an eye clinic for a check-up. This
population may not reflect a typical cohort in a general pediatric clinic setting being seen for
routine well child exams. Ethical issues were taken into consideration. Yan et. al discussed how
findings were important in clinical practice and where research was still needed.
Level IV Evidence
Six physicians on behalf of the American Association for Pediatric Ophthalmology and
Strabismus organizations (AAPOS) performed a prospective population-based study review on
a pediatric population ages 12 month to greater than 72 months (Donahue et al., 2013). The
review was done to help develop and update guidelines to improve reporting of results and
comparison technologies for detecting amblyopia. Updated guidelines would help propose and
determine levels for detecting amblyopia risk factors to separate those children who are at most
risk with those children who are not (Donahue et al. 2013). Donahue et al. reported several
prospective population based studies to show childhood amblyopia prevalence was
approximately 2%, same as previous reports. However, prevalence of amblyopia risk factors
was greater than previously thought at approximately 15%-20%. These numbers showed that
not all children with amblyopia risk factors develop amblyopia and this finding was confirmed by
a longitudinal follow-up study.
Findings from the reviewed studies led Donahue et al. (2013), to search for information
to update referral guidelines to decrease “over-referrals.” Donahue et al. recommended vision
screenings should take place at several intervals during the early developmental years instead
of one particular time in early childhood. Findings also revealed refractive risk factor targets with
automated preschool vision screenings. Donahue et al. concluded as technology continues to
advance, reassessment of means for detecting amblyopia and amblyopia risk factors will need
to take place to maintain sound screening tools.

32

SCREENING AMBLYOPIC FACTORS 33
Critical appraisal for these guidelines ranked as high. Donahue et al. (2013) had a valid
development strategy which was explicit, sensible, and used an impartial process to identify and
select evidence. The guidelines did not make explicit recommendations but rather
recommendations that are applicable to general practice vision screenings. It was not noted if
the guidelines had been subjected to peer review and each guideline was not tagged by
strength of evidence in which it was linked with scientific evidence. Recommendations for use in
the national arena of providers were clinically relevant outcomes that can be measured through
standard care.
The U.S. Preventive Services Task Force (USPSTF) is one organization that helps set
guidelines for clinical practice. In 2011, the USPSTF updated vision screening guidelines in
children ages 1 year to 5 years. The USPSTF acknowledged 2 to 4 percent of pre-school aged
children had amblyopia recognizing a possible cause for this as an alteration in the visual neural
pathway in the developing brain. If amblyopia is left untreated it can lead to permanent vision
loss. Based on review of the information, the USPSTF agreed vision screening tools, including
AVS, have reasonable accuracy to detect visual disorders. The USPSTF also found adequate
evidence that early detection and treatment of amblyopia improves visual outcomes with
moderate certainty in ages 3 years to 5 years. The USPSTF discussed limited evidence on the
harms of vision screenings.
Final conclusions by the USPSTF (2011) for visual screening guidelines included:
adequate evidence of early treatment of amblyopia in children younger than 3 years leads to
improved outcomes. There was inadequate evidence for recommendations of intervals for vision
screening. Screening and treatment later in preschool years appeared to be effective but may
take longer to resolve thus increasing financial burden on families.
Critical appraisal score given to the USPSTF (2011) summary guidelines was a high.
The updated USPSTF guideline used a valid development strategy which was explicit and
sensible. The USPSTF used an impartial process to identify and select evidence. The
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guidelines did not make explicit recommendations but recommendations that are applicable to
general practice of vision screenings. It was not noted if the guidelines had been subjected to
peer review and each guideline was not tagged by strength of evidence in which it was linked
with scientific evidence. The updated guidelines by the USPSTF provides for use in the national
arena of providers which were/are clinically relevant listing outcomes that can be measured
through standard care.
Level VI Evidence
In a cross-sectional study, Chang et al. (2015) looked at 137 preschoolers attending six
different preschools in O’ahu Hawai’i. Ages screened ranged from 8 months to 5 years 2
months. Race characteristics of the preschoolers included: 48 full/part Hawaiian or Pacific
Islander, 56 of mixed races, 21 Asian, and 12 Caucasian. The purpose of the study was to look
at ease of use of hand-held portable vision screeners in the preschool setting. Chang et al.
found 108 (79%) of the preschoolers passed the screening. Four were referred for astigmatism,
four referred for hyperopia, one referred for gaze asymmetry, and two referred for
anisometropia. Cycloplegic eye examination was not done to compare vision screening results.
However, Chang et al. concluded the hand-held screening device has the potential to facilitate
early vision screening in preschools in Hawaii. The AVS was quick and easy to use and also
well tolerated by pre-school children.
Critical appraisal score for Chang et al. (2015) cross-sectional study is low. The research
design was appropriate for the aims of the research along with the recruitment strategy.
However, fall out reasons were not listed or discussed. The study consisted of a small
population size and the varied environments where screenings were done were not consistent.
The lighting in each location was different and not taken into account when first setting up
screening stations. Too much or too little light affects the screening results by the hand-held
vision screener, therefore lighting is important. No in depth statistical analysis were discussed or
sensitivity and specificity calculated due to poor referral follow-up for cycloplegic retinoscopy to
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compare results to the hand-held screener. The cross-sectional study by Chang et al. did offer
good information on ease of use by lay persons and tolerability of preschoolers.
The Lions Club of western South Dakota performed vision screenings on children ages
six months to 12 years with the mean age being 79 months. Screenings took place in five
different school and community center locations (Terveen, Moser, & Spencer, 2015). A total of
4,722 children were screened with 2,373 being female and 2,349 being male. Terveen, Moser,
and Spencer set up a quantitative descriptive design to look at data collection on the SPOT™
photoscreener in the South Dakota pediatric population. Data were stratified by age group with
four different age groups: 12months -30months; 31months - 48months; 49months – 72months;
and 73months – 144months. Data were collected on sex and percentage of children referred for
hyperopia, myopia, astigmatism, anisocoria, anisometropia, and ocular misalignment. Sex was
compared using chi-square test.
Results from Terveen, Moser, and Spencer’s (2015) descriptive trial showed 563 failed
the vision screening with the SPOT. No significant difference was noted in referrals based on
sex (p = 0.598). Children 73 months – 144 months had the highest referral rate at 12.2%.
Children twelve months to thirty months had the lowest referral rate at 7.9%. Reasons for
referral included: 371 (7.9%) astigmatism; 24 (0.5%) for ocular misalignment; 101 (2.1%)
anisometropia; 135 (2.9%) myopia; 36 (.8%) for hyperopia; 16 (0.3%) anisocoria. There was an
overall referral rate of 11.9% using the SPOT™. Terveen, Moser, and Spencer also found a
cost benefit of early amblyopia screening. If left untreated, amblyopia can diminish a 30-year,
income in South Dakota, by $281,510.00. The 30-year loss was generalized to be
approximately a $23 million yearly loss in earning power for the western South Dakota area
workforce.
Conclusion of Terveen, Moser, and Spencer (2015) was early detection and treatment
result in quicker outcomes as effectiveness of treatment has been shown to decrease as
children get older. Also, early detection with early treatment has been shown to decrease length
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and cost of treatment. Medium ranking was given to this source for critical appraisal. The aim of
the research was clearly stated. The qualitative methodology was appropriate for this study and
appropriate to address the aims of the research. Statistical analysis was performed to show
abnormal screening results and percent of individuals referred with the reason for referral.
However, no statistical analysis was performed to show sensitivities and specificities of the
SPOT™ photoscreener. Bias considerations were also not discussed in regard to the role of the
researchers but researchers did discuss poor follow-up accounting for inability to calculate and
compare date to cycloplegic retinoscopy.
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Table 2.2
Levels of Evidence
Author(s),
Level of
Evidence

Population
Setting

Arnold, R.
W., &
Armitage, D.
(2014)

108 Children
ages 1 to 12
years in
Alaska
Pediatric Eye
Practice

Level II

Design, Intervention(s)

Outcomes

Random Controlled Trial

Each photoscreener had sensitivity
and Specificity as well as positive
predictive values >80% except the
iScreen® screener

Pediatric Eye exams performed
using four different photoscreeners
(GoCheckKids™, PlusOptix S09™,
SPOT™, iScreen 3000®)

Appraisal Score

Medium
Interpreter of visual images
was not completely blinded to
patient identities
Researchers were not
accustomed to the
GoCheckKids™ screening
tool

Each patient was screened using
four different automated vision
screeners in random order by
orthoptist and pediatric
ophthalmologist. Orthoptist and
pediatric ophthalmologist did not
know results of any previous
readings

Individuals screened were
attending an eye clinic, may
not be good representation of
general pediatric clinic
population
Statistical outcomes were
given. Validation statistics
using a 2X3 table to show
sensitivity and specificity of
each photoscreener used. No
in-depth statistical analysis
Good information with
sensitivities and specificities
were provided for each
photoscreener
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Author(s),
Level of
Evidence
Chang et al.,
2015

Level VI

Population
Setting

Design, Intervention(s)

137 Preschool age
at six different
preschools in
O’ahu Hawai’i. Age
range 8 months to
5 years 2 months

Cross-sectional study design

Race included 48
full/part Hawaiian
or Pacific Islander,
56 mixed races, 21
Asian, 12
Caucasian

Outcomes

108 preschoolers (79%) passed
the screening
4 referred for astigmatism
4 referred for hyperopia
1 referred for gaze asymmetry
2 referred for anisometropia
Sensitivity and specificity data
were not obtained due to lack of
follow-up for referrals

Appraisal Score

Low
Research design was appropriate
for the aims of the research
Recruitment strategy was
appropriate for aims of research
design
Fall out was not listed
Small population size

Photo screener was quick and
easy to use and well tolerated by
pre-school children

Environments for screenings
varied; lighting was not taken into
consideration when setting up
screening stations
No in depth statistical analysis
discussed with sensitivities,
specificities, CI, OR
Poor follow-up to compare and
calculate results from cycloplegic
retinoscopy
Did offer good information on
results in general and tolerability
for screeners and screeners
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Author(s),
Level of
Evidence
Donahue, S.
P., Arthur,
B., Neely, D.
E., Arnold, R.
W., Silbert,
D., & Ruben,
J. B. (2013,
February)

Level IV

Population
Setting
Pediatric
preschool
population (12
months to>72
months)

Design, Interventions

Prospective population-based
study review
Six physicians on behalf of
American Association for
Pediatric Ophthalmology and
Strabismus developed new
guidelines to improve reporting
of results and comparison of
technologies of detecting
amblyopia. To propose levels for
detecting amblyopia risk factors
to separate those children who
are at most risk with those
children who are not

Outcomes

Prevalence of amblyopic risk factors
higher than previously thought at 15%
to 20%
Vision screenings should take place at
several intervals during early
development years instead of 1
particular time in early childhood
Recommendation/Guidelines updated:
Detection of amblyopia risk factors in
toddlers (12-30 months)
Detection of amblyopia risk factors
early in preschool children (31-48
months)
Detection of amblyopia risk factors in
late preschool and kindergarten
children 49-72 months
Detection of amblyopia risk factors in
school-aged children (>72 months)
Detection of amblyopia and decreased
visual acuity using traditional
(Optotype-based) screening
Detection of amblyopia and decreased
visual acuity using instruments other
than photoscreeners and
autorefractors
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Appraisal Score

High
Valid development strategy
was explicit & sensible; used
impartial process to identify
and select evidence; was
used for review to improve
guidelines
Guidelines did not make
specific, explicit
recommendations but
recommendations applicable
to general practices
performing vision screenings
Was not noted if guidelines
were subject to peer review
Each guideline was tagged by
strength of evidence which it
was linked with scientific
evidence
Recommendations provided
for use in national arena of
providers; recommendations
were clinically relevant, listing
outcomes that can be
measured through standard
of care
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Author(s),
Level of
Evidence
Mu, Y., Bi, H.,
Ekure, E.,
Ding, G., Wei,
N., Hua, N., ...
Li, X. (2016,
February 16)

Level III

Population
Setting
Pediatric
population
ages 4 to 7
years at
Tianjin
University
Hospital eye
clinic in
Helsinki

Design, Intervention(s),
Comparisons

Outcomes and
Effect Measures

Non-randomised control trial

155 were screened, 71 were girls,
84 were boys; 26 (16.8%) had
amblyopia risk factors. 115 (74.2%)
had amblyopic risk factors; 65 had
hyperopia, 28 had myopia, 59 had
astigmatism, 32 has anisometropia,
and 37 had strabismus

Compare visual screening with Spot
photoscreener to traditional
cycloplegia retinoscopy

Wilcoxon signed-rank test showed
difference was not statistically
significant at a p value of <0.01

155 children
attending
eye hospital
for
screening or
a check-up
were
screened

Linear, quadratric, cubic models
were constructed to assess
correlation between the two
screenings
Bland-Altman showed moderate
agreement between the SPOT
photoscreener and cycloplegic
retinoscopy
Spot showed high sensitivity
(94.79%) and specificity (85%) in
detecting amblyopia risk factors
based on AAPOS 2013 guidelines
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Appraisal Score

High
Aim of research was clear
Ethical and bias issues were
addressed
Statistical analysis was
discussed in detail
Limitation noted: population
screened had a high
prevalence of amblyopia risk
factors compared to
community population or
school based samples as
screening took place at
ophthalmology clinic
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Author(s), Level
of Evidence

Population
Setting

Oregon
Evidence-based
Practice Center
(2011)

Children
ages 1-5

Level I

Design and Intervention(s)

Systematic review
Looking at randomised trials and
controlled observational studies that
evaluated screening for impaired visual
acuity in preschool aged children
Looking at randomised trials and
controlled observational studies that
reported outcomes associated with
treatments
Two independent investigators
assessed study quality

Outcomes

Reviewers found: No randomised
control trials compared preschool visual
screenings to no preschool screenings
One study found repeated screening,
from ages 8 months to 37 months, most
likely reduced amblyopia by age 7.5
years
One study found a one-time vision
screening at age 37 months had no
significance difference at risk for
amblyopia by age 7.5 years compared
to no screening
No screening test had both high
sensitivity and high specificity
3 studies showed preschool age
children w/ amblyopia or unilateral
refractive error receiving treatment
resulted in small improvement at 5
weeks post treatment or after 1-year
post treatment but improvement was
noted
Conclusion: more evidence needed to
compare early screening and treatment
to later screening and treatment of
visual problems such as amblyopia or
refractive error
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Appraisal Score

High
Clearly addressed
focused questions
Large assortment of
study trials was
included
Detailed rigor of
studies included with
overall results listed
in review
All important
outcomes were
considered
Did report limiting
factor as studies
were done within a
specific community
setting or
ophthalmology
setting which might
be limiting as may
not apply to general
pediatric clinic
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Author(s), Level
of Evidence

Population
Setting

Powell, C., &
Hatt, S. R.
(2009)

Pediatric
population

Design, Intervention(s)

Outcomes

Appraisal Score

Systematic review

1449 total articles identified

High

Randomised controlled trials,
cluster-randomised trials

3 articles were kept

Clearly addressed
focused questions

None were randomised controlled trials
Level I

To review and evaluate vision
screening and its results on
amblyopia compared to nonscreened pediatric population

Best studies were used
Information obtained is from observational
studies
Prevalence of amblyopia was measured;
Preschool group had slightly better
outcomes reported in treatment compared
to school age children treated

Two authors independently
assessed summaries of
electronic search results

No screening protocol clarified

Multiple databases
were used to find
sources
Rigor used to assess
quality of studies found
Overall: results were
clear

Determined more evidence needed
Specific statistical
analysis (CI, OR) were
indicated
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Author(s),
Level of
Evidence
Singman, E.,
Matta, N.,
Fairward, A., &
Silbert, D.
(2013)
Level III

Population
Setting
Autistic
pediatric
population,
ages <1yr to
15 yr., with
average age
of 6 years
48 children
were
identified
with autism
for this study,
25 were final
number
screened

Design, Intervention

Outcomes and
Effect Measures

Retrospective medical records
review

17 (68%) were found to have amblyopia
risk factors

Children were tested 2 times

2nd testing found the same 17 with
amblyopia risk factors

Goal was to compare reliability of
PlusOptix photoscreener to
traditional pediatric vision screen
in a pediatric population with
autism

PlusOptix photoscreener was found to
have sensitivity of 88%, specificity of 87%,
positive predictive value of 94% and
negative predictive value of 78%
Conclusion by Singman et al = is difficult to
get reliable screening results in children
with autism; the PlusOptix vision screener
provides a quick and reliable way of
screening

Appraisal Score

Low
Aim of the research
was clearly stated
Qualitative
methodology was
appropriated to
address aims of the
research
Data were gathered in
a way to address the
research question
Biases, limitations, and
ethical issues were not
discussed
No statistical analysis
information was
detailed with
sensitivities,
specificities, false (+),
false (-), PPV or NPV,
CI, OR
No in-depth discussion
on how findings relate
to other studies in
literature
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Author(s),
Level of
Evidence
Terveen, D. C.,
Moser, J. M., &
Spencer, T. S.
(2015)

Level VI

Population
Setting

Design, Intervention(s)

Children
ages 6
months to 12
years (mean
age was 79
months)
were
screened by
trained Lions
Club
volunteers
using Spot
photoscreen
er

Quantitative descriptive design

563 failed the screening

Medium

Indications using Spot
photoscreener indicated no
follow-up or referral for
complete eye exam

No significance difference in referrals
based on sex (p=0.598)

Aim of the research was
clearly stated

Children 73-144 months had highest
referral rate (12.2%); 12-30 months
had lowest referral rate (7.9%)

Qualitative methodology was
appropriate for this study and
appropriate to address the
aims of the research.

Final group
of 4722
children
screened,
2373 were
female, 2349
were male

Data stratified by age group; 4
different age groups: 12-30mo,
31-48mo, 49-72mo, 73-144mo;
Data stratified for sex and
percentage of children referred
for hyperopia, myopia,
astigmatism, anisocoria,
anisometropia, and ocular
misalignment
Sex was compared using chisquared test

Outcomes

Reasons for referral: 371 (7.9%)
astigmatism, 24 (0.5%) ocular
misalignment, 101 (2.1%)
anisometropia, 135 (2.9%) myopia,
36 (0.8%) hyperopia, 16 (0.3%)
anisocoria
11.9% overall referral rate using Spot
screener
Cost benefit of amblyopia was found
to be favorable, showing untreated
amblyopia can diminish a 30-year
income by $281,510.00;

Took place in
five different
community
locations by
Lions Clubs
in western
South
Dakota

44

Appraisal Score

Statistical analysis was
performed to show abnormal
screening results and percent
of individuals referred with
reason for referral
No statistical analysis was
discussed to show sensitivities
and specificities of the SPOT
photoscreener
Bias considerations were not
discussed in regard to the role
of the researchers; did discuss
poor follow-up accounting for
inability to calculate and
compare date to cycloplegic
retinoscopy
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Author(s),
Level of
Evidence
U.S Preventive
Services Task
Force. (2011)

Level IV

Population
Setting

Design, Intervention(s)

Pediatric
population, 1
to 5 years of
age

Summary recommendations for
vision screening in children

Outcomes

Recommends vision screening all
children ages three to five years of
age with Grade B evidence
Found adequate evidence of benefits
of early detection and treatment of
amblyopia improves visual outcomes
with moderate certainty in ages 3
years to 5 years
Limited evidence on harms of vision
screenings
Adequate evidence of early
treatment of amblyopia in children
younger than 3 years leads to
improved outcomes
Did not find adequate evidence for
recommendations of intervals for
vision screening
Found screening and treatment later
in preschool years appears to be
effective but may take longer to treat
increasing financial burden
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Appraisal Score

High
Used valid development
strategy which was explicit and
sensible; Used impartial
process to identify and select
evidence
Guidelines did not make
specific, explicit
recommendations;
recommendations were
applicable to general practices
of vision screenings
Was not noted if the guidelines
were subjected to peer review
Each guideline was not tagged
by strength of evidence in
which it was linked with
scientific evidence
Updated guidelines provide for
use in the national arena of
providers which were clinically
relevant; outcomes listed can
be measured through standard
care
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Author(s),
Level of
Evidence
Yan, X.,
Jiao, W.,
Li, Z., Xu,
W., Li, F.,
& Wang, L.
(2015,
June 1)

Population
Setting

Design, Intervention(s)

Children ages
2 to 14 years
attending an
ophthalmology
clinic at
Provincial
Hospital in
Shandong
Helsinki

Controlled trial without randomization

Level III
178 pediatric
patients
(100 males, 78
females)

To assess the accuracy of PlusOptix
A09 photoscreener in detecting
amblyopia risk factors in children
Comprehensive ophthalmic exam in
order: PlusOptix A09, orthoptic exam
with prism alternative and cover test,
anterior segment assessment using
slit lamp, fundus exam with
cycloplegic retinoscopy
Data analysis to compare refractive
measurements between PlusOptix
and cycloplegic retinoscopy were
calculated

Outcomes

86 (48.3%) children diagnosed with
amblyopia
63 (35.4%) children diagnosed with
strabismus
With mean deviation of 27.1 ± 18.5 PD

Appraisal Score

High
Aims of research clearly
stated with appropriate
methodologies applied

Sensitivity for detecting refractive
amblyopia risk factors was 80.6%

Recruitment was clearly
stated with reasons for
exclusions

Specificity for detecting refractive
amblyopia risk factors was 76.3%

Data collection was clearly
reported

After applying ROC curve, overall
sensitivity of PlusOptix A09 in detecting
refractive amblyopia was 94.9% and
specificity for detecting refractive
amblyopia was 63.2%

Potential bias: population was
already attending eye clinic.
May not be easily applied to
general pediatric clinic
population

Spherical equivalent showed significant
difference between PlusOptix and
cycloplegic retinoscopy with p = 0.00

Ethical issues were
considered

Paired t-test showed p = 0.14 for mean
cylinder power value (Jackson cross
cylinder at axis 0 0) and p = 0.26 (Jackson
cross cylinder at axis 45 0)
Bland-Altman plots showed agreement
between the PlusOptix A09 and
cycloplegic retinoscopy for spherical
equivalent
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Consistency measurements from
PlusOptix A09 and cycloplegic retinoscopy
confirmed with Pearson’s correlation
coefficient (r = 0.95, p = 0.00)
Conclusion = PlusOptix A09 is useful in
large scale screenings of refractive errors
but may not be suitable for large scale
strabismus screening
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Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
Amblyopia is the most common visual disorder in children and is potentially curable if
detected early and treated properly in the first few years of life. Amblyopia is the leading cause
of monocular vision loss in children (Bradfield, 2013). Other visual abnormalities include
refractive errors such as myopia, hyperopia, and astigmatism causing blurring of vision.
Retinoblastoma is another vision concern requiring early screening to detect and mitigate before
it causes long term effects (Hered, 2011). In children, visual impairment can delay learning
causing children to be inadequately prepared to start preschool or kindergarten. Delayed
detection of visual problems can lead to neural visual pathways not developing properly
therefore causing irreversible vision loss (AAP, AACO, AAPOS, AAO, 2003; Bradfield, 2013;
Chang et al. 2015; Forcina et al., 2017; Hered, 2011; USPSTF, 2011).
It has been shown in the literature that early detection and treatment of amblyopia and
amblyopic risk factors between the ages 3 years and 5 years lead to improved visual outcomes
and has moderate net benefit (USPSTF, 2011). Sources reveal early detection, especially in
preschool years, of vision abnormalities can result in full recovery of vision and decrease
developmental abnormalities of binocular vision (AAP, AACO, AAPOS, AAO, 2003; Bradfield,
2013; Forcina et al., 2017).
Data within the literature demonstrated automated visual screening instruments, also
known as photo screeners, have become more accurate at detecting visual abnormalities
specifically amblyopia, amblyopia risk factors, refractive errors, and strabismus in the pediatric
population, ages six months to five years (Arnold & Armitage, 2014; Mu et al., 2016; Powell &
Hatt, 2009; Singman et al., 2013; Yan et al., 2015). AVS provide practical, fast, and easy vision
screenings. Most AVS screen both eyes simultaneously, accommodating a short attention span
of a young, non-verbal child or a child with autism or learning disabilities (Bradfield, 2013;
Peterseim et al., 2015; Terveen, Moser, & Spencer, 2015; Yilmaz et al., 2015).
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PlusOptix™ photoscreeners have been shown in the literature to have a high sensitivity
for detecting amblyopia and amblyopic risk factors and specificity for detecting those individuals
without amblyopia and amblyopic risk factors (Mu et al., 2016; Singman et al., 2013). Singman,
Matta, Fairward and Silbert (2103) reported the PlusOptix SPOT™ photoscreener to have a
sensitivity of 88% and a specificity of 87% for detecting individuals with and without amblyopic
risk factors. Mu et al. (2016) reported the PlusOptix™ photoscreener having a sensitivity of
94.79% and specificity of 85% for detecting amblyopic risk factors.
Overall results from literature show that automated photoscreeners, including the
PlusOptix™ series, are easy to use, time-saving, have good compliance with children, and are
accurate in detecting visual abnormalities in the young pediatric clients.
Best Practice Model Recommendation
Based on the evidence, children ages six months to five years need early vision
screening for early detection of amblyopia, amblyopia risk factors, strabismus, and
retinoblastoma to prevent long term vision loss. Using the evidence found in the literature, the
project manager used Nola Pender’s HPM and the Stetler evidence practice model to guide the
new clinical practice change. The EBP project incorporated automated visual screeners, the
PlusOptix™ in particular, into well child exams within pediatric clinics located in a large Midwest
city.
Vision screenings took place using the PlusOptix™ at ages 9 months, 24 months, 36
months, and 48 months. Boxes were created by IT in the EHR under the visual screening tab for
nurses to document “pass” and “refer” from the PlusOptix™ results. A copy of the results from
the PlusOptix™ were printed and placed in the patient’s EHR. The printout contained specific
abnormalities found from the screening. Any failed vision exams were referred to onsite
ophthalmology or ophthalmology of the parents’ choice. The project leader followed-up with
patients, via EHR, who were referred to ophthalmology to compare traditional eye screening
results to the printed results of the PlusOptix™. The EBP project leader also compared
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PlusOptix™ results on a set number of patients over three months using the PlusOptix™ in the
clinic setting to three months of vision screening referrals prior to implementation of the
PlusOptix™. This comparison helped provide evidence on the accuracy of the PlusOptix™
within the clinic setting by comparing referral rates of the pre-implementation group to the postimplementation group and showing sensitivity.
How the Best Practice Model Will Answer the Clinical Question
The best practice recommendation answered the clinical question: In a pediatric
population aged 9 months, 24 months, 36 months, and 48 months, how does early vision
screening using automated photo vision screeners compared to traditional vision screening
techniques affect the number of refractive errors detected within three months. The hope was by
performing vision screenings with the PlusOptix™ in the stated population then comparing the
results to the results of vision screenings performed by traditional screening methods, prior to
the use of the PlusOptix™, the clinical question would be answered.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
Participants and Setting
A total number of 322 preschoolers were recruited in the sample with 161 in each
the pre- and post-implementation groups. It was estimated 100 pediatric patients would be
screened in the post-implementation group based on the number of WCC from the previous
year in the same three months. Pre-implementation vision information was obtained from EHR
once post-implementation data was collected and the number was known with the assistance of
IT personal at the clinic site. The pre-implementation group was identified based on age groups,
WCC, and same providers as the post-implementation group. One-hundred-sixty-one WCC
were performed in the post-implementation group using the EBP project parameters, therefore
that became the size of each sample group.
The setting for this EBP project was a general pediatric clinic in a large Midwest city. The
pediatric clinic is part of a large not-for-profit organization that sees clients of various ethnic and
socioeconomic backgrounds. There are six different pediatric clinics with many pediatric
providers. However, only one clinic and two providers WCC information was used to collect data
regarding vision screening results and referrals. Participants were pediatric clients in the clinic
for a well-child check at ages 9 months, 24 months, 36 months, and 48 months.
Data collected post-implementation was to show the specificity and sensitivity of the
PlusOptix™ comparing vision screening results to the pre-implementation group. The project
was to compare data of vision screenings using the PlusOptix™ over a 3-month period to vision
screening results using traditional visual screening methods performed by pediatric providers
from three months prior to implementation of the PlusOptix™ in order to compare referral rates.
Data collected post-implementation of the PlusOptix™ also compared screening results from
failed PlusOptix™ screenings to ophthalmology screenings after being referred by the pediatric
provider to look at sensitivity.
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Outcomes
Data collection took place over a three-month period. Data collected postimplementation of the PlusOptix™ was compared to data collected from screening results 3
months prior to implementation of the PlusOptix™. Data were also collected from
ophthalmology referral results post-implementation and compared to the child’s PlusOptix™
results. It was believed the data collected would show ability of the PlusOptix™ photoscreener
to detect visual abnormalities, specifically amblyopia, and amblyopic risk factors accurately at
the early ages of 9 months, 24 months, 36 months, and 48 months. Data analysis on these two
groups was to show accuracy, specificity, and sensitivity.
Intervention
Vision screenings took place in the above-mentioned Midwest pediatric clinic using the
PlusOptix™ at ages 9 months, 24 months, 36 months, and 48 months. Data collected was not
only to show specificity and sensitivity of the PlusOptix™ but also to show accuracy in the age
groups 9 months, 24 months, 36 months, and 48 months. The previous traditional visual
screenings at WCC included the Snellen chart starting at age 4 years by some pediatric
providers and at kindergarten age by other pediatric providers. Vision problems are difficult to
screen for in this age group using traditional eye charts due to the child’s preverbal
development, the inability to recognize objects and letters, and the inability to cooperate due to
age and attention span. Previously, Snellen chart screenings were also done at sports physical
check-ups or if there were a concern by a parent, teacher, or other contact person of the child.
At all WCC, a visual exam by the provider was performed without the use of cycloplegia
retinoscopy as cycloplegia is typically done in an ophthalmology clinic. Screening with
PlusOptix™ offers the advantage of being able to fully screen the 9 months, 24 months, 36
months, and 48 month age groups, thereby increasing the available data starting at an earlier
age. Limitations of traditional vision screenings methods of Snellen chart and pediatric provider
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visual exams during WCC had prevented children in these age groups from being fully screened
for refractive errors at this clinic.
Boxes was created by IT in the electronic health record (EHR) under the visual
screening tab for nurses to document “pass” or “refer.” Nurses were to check the appropriate
box once screening was completed using the PlusOptix. ™ This documentation screen was also
used to generate billing for the screenings. If documentation does not occur in this screen, a
patient or their insurance is not billed. If the child was unable to be screened the nurse had the
option to long hand document in the vision screening tab that information and why they were not
screened. The nurse was to use the word “NULL” on the project flow sheets if a child was not
screened or was unable to be screened and give the reason such as small eyes, uncooperative,
or already seeing ophthalmology. A copy of the results from the PlusOptix™ was printed and
placed in the patient’s EHR. The printout contained specific abnormalities found from the
PlusOptix™ screening. Any failed vision exams were referred to onsite ophthalmology or an
ophthalmology of the parents’ choice. Data were collected over three months postimplementation of the PlusOptix™ using flow sheets in the clinic and by EHR. Data were also
collected for three months pre-implementation for comparison. The project leader followed-up
with patients, via EHR, who were referred to ophthalmology to compare ophthalmology eye
screening results to the child’s PlusOptix™ “refer” printed results kept in the child’s EHR. The
comparison was to show sensitivity and specificity of the PlusOptix™.
Planning
Approval to implement the PlusOptix™ was granted by the medical board, which
governs policies and procedures for the pediatric clinics, after best practice evidence
information was provided. Initial request for the PlusOptix™ was presented along with
information received from current literature to pediatric providers working within the pediatric
clinics. Information from the literature was disseminated to providers and a capital request form
was filled out and submitted by nursing administration. After receiving feedback from providers
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and nursing administration, evidence was presented to the medical board where approval was
granted for the use of the PlusOptix™ vision screener within the pediatric clinics. Approval was
also obtained by Valparaiso University and the project facility’s Internal Review Boards.
Staff education was conducted by selecting superusers from each clinic. Superusers
were chosen based on those who volunteered to be trained as such. The project manager,
nursing administration, and superusers received formal education on the PlusOptix™
photoscreener via Skype® from a PlusOptix™ Inc consultant. There was also a PowerPoint®
that was part of the training by the PlusOptix™ representative as well as online videos walking
the viewer through the process of using the PlusOptix screener™. The videos included use,
meaning of test results, maintenance, and troubleshooting of the PlusOptix™. Individual staff
members within the individual clinics were trained with the use of the online videos provided by
PlusOptix™. The staff members watched the videos and reviewed the PowerPoint® during a
staff meeting and those who were not able to attend the staff meeting set up a time with the
project manager or supervisor to watch the training videos and demonstrate competency.
Competency was checked off using an attendance roster flow sheet (see Appendix A) as each
staff member accurately demonstrated back proper use, cleaning, and storage of PlusOptix™.
Staff members were also required to demonstrate proper use of the photoscreener on a
superuser or the project manager and on one patient. A “cheat sheet” (Quick reference guide)
provided by PlusOptix Inc™ (see Appendix B) was given to each staff member with use and
meaning of vision screening results. A copy of the “cheat sheet” was also kept with the
PlusOptix™ for easy access while using the photoscreener.
Data
Measures
One group in which data were collected was the portion of patients where refractive
errors were detected by the PlusOptix™ (post-implementation). Post-implementation data of
failed screenings was compared to visual screening results from ophthalmology after referral
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was made. The project manager was able to access and follow-up on ophthalmology results via
EHR if the child was seen by ophthalmology within the same organization. If a child was not
seen for referral within the same organization, referral results were unknown. Another group
was the portion of patients screened, pre-implementation of the PlusOptix™ by pediatrician’s
visual exam and Snellen Chart. Pre-implementation group data were chosen randomly with the
help from IT. A chi-square goodness of fit test was performed to check which group would find
more refractive errors. A chi-square test was also performed to test for any significance of
results based on gender or race. An independent-samples t-test was performed to test for
differences between both groups based on age. Both sets of data were normally distributed and
measured using the same criteria of pass or refer, and number of failed screenings found
between the PlusOptix™ post-implementation and the traditional screening pre-implementation.
Data collected was statistically analyzed after input into the most current SPSS system,
a computer program for statistical analysis.
Collection
Data collection post-implementation was tracked by flowsheets in the pediatric clinic.
One flowsheet contained four columns; one for the medical record number, one for DOB, one
for PlusOptix™ results (pass, refer), and one for an assigned identification number (IDN), (see
Appendix C). Another flow sheet contained four different columns to de-identify data; one
column for IDN, one for the PlusOptix™ results, one for the Ophthalmology results if referred,
and one for DOB (see Appendix D). The same flow sheets were created for pre-implementation
data (see Appendices E & F). PlusOptix™ screenings and screening results were also kept in
each child’s EHR. Screening results scanned into the patient’s chart from the PlusOptix™
contained detailed results such as eye/pupil measurements, alignment and refractive errors.
Nursing staff recorded patient’s medical record number, date of birth, pass, refer, or NULL on
the flow sheets of children within the specified age group having visual screenings with the
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PlusOptix™. If “NULL” was listed in the results column a notation was made as to why no
results were obtained such as uncooperative or eyes too small.
The project manager assigned an IDN once the flowsheet had been filled or at the end
of data collection whichever came first. Nursing staff also recorded results in the correct location
of each child’s EHR. A printed copy of the PlusOptix™ results from the remote PlusOptix™
printer was scanned into the EHR and became a permanent part of the EHR. Once results were
documented within the patient chart, the project manager used the flowsheet to locate the
results. Vision screening results were obtained from the same number of charts, within the
same age groups, on children receiving screenings during WCC, 3 months prior to
implementation of the PlusOptix™. Charts were chosen randomly with assistance from IT.
Some post-implementation data were obtained solely from the EHR with the assistance of IT as
implementation of the PlusOptix™ was implemented by providers prior to full IRB approval for
data collection by the project site. IRB approval was given for this process as well. Pre-and
post-implementation data were compared to determine referral rates of detecting refractive
amblyopic risk factors between the two groups. PlusOptix™ failed results were compared to
ophthalmology results to help show sensitivity and specificity.
Management and Analysis
Management of the flowsheets was taken into great consideration as to not compromise
the identity of each child screened. The initial flowsheet was securely located in a locked
cupboard with the PlusOptix™ at the nurse’s station at the end of each clinic day. The second
flowsheet, that the project manager used, was kept in a locked file cabinet in the supervisor’s
office when the project manager was not on site. The only patient identifiers on the flow sheets
were DOB and medical record number.
Once all data were obtained the project manager reviewed all data collected by
comparing data on the flowsheets to data within each individual’s chart. The project manager
also reviewed appointment schedules for the three months post-implementation to make sure
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no WCC visual screenings were missed on the data collection flow sheets. Data were then
organized using an SPSS code book so data could be entered into the most current version of
SPSS for analysis.
A chi-square test was performed to compare the two groups and show referral rates. It
also looked at statistical differences based on gender and race. An independent-samples t-test
was performed using data collected in order to show if there was a statistical difference based
on age between the two groups.
Any follow up/referrals seen outside the clinics network were inaccessible for review and
comparisons.
Protection of Human Subjects
Institutional Review Board (IRB) approval was obtained from Valparaiso University and
the project facility’s IRB prior to implementing this EBP project. There were no patient identifiers
transcribed on any written material or stored in any databases, spreadsheets, or word
documents. No protected health information (PHI) was put into the PlusOptix™, which is
possible with this screener so patient data can be directly uploaded into the patient’s chart. By
not imputing PHI into the PlusOptix™ patient information is protected in the event the vision
screener became missing or stolen. Flowsheets with patient medical record number and DOB
were kept in a locked cupboard at the nurse’s station and in the supervisor’s office at the end of
each clinic day so it is easily accessible to the nursing staff and the project manager but secure
to protect information. The project leader was able to locate patient’s vision screening results
within the EHR by using medical record number information and DOB from the flowsheet. The
project leader was also able to track referrals to ophthalmology through the EHR and follow-up
screenings if done within the same facility so no release of information was needed by parents
or guardians. Follow-up results for anyone seeing ophthalmology outside of the clinics network
were inaccessible for comparison.
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CHAPTER 4
FINDINGS
The PICOT question for this project was: In a pediatric population aged 9 months, 24
months, 36 months, and 48 months, how does early vision screening using an automated photo
vision screener, compared to traditional vision screening techniques affect the number of
refractive errors detected within three months? The purpose of this EBP was to implement an
automated visual screener at all well-child visits for the ages listed within the PICOT question to
check for amblyopia risk factors and refractive abnormalities. Pre-implementation screenings for
these age groups were performed by the provider using ophthalmoscope without cycloplegic
retinoscopy (pupil dilatation). Snellen chart was used only for those receiving a kindergarten
well check. No Snellen chart screenings were used on the age groups listed above unless there
was a concern by a parent, legal guardian, or school program. Screening for these age groups
post-implementation was performed using the PlusOptix S12™ automated visual screener.
This chapter provides data on the participants’ characteristics using descriptive statistics,
independent t-test, as well as the Chi-Square Goodness of Fit test for the outcome measure.
Participants
Size and Characteristics
This EBP practice project was implemented in a Midwest pediatric clinic during well-child
check-ups for ages 9 months, 24 months, 36 months, and 48 months. It included all children in
these age groups from different genders and races. No one was excluded. Data were captured
on those that were unable to be screened due to lack of cooperation, already seeing
ophthalmology, or some other reason not documented and recorded as “NULL” on the data
collection flow sheet.
A total of 322 children were recruited in the sample size with 161 children in each the
pre- and post-implementation groups. Three were lost to attrition in the pre-implementation
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group (final n = 158) and 14 in the post-implementation group (final n = 147). Attrition from these
groups was due to unwillingness to cooperate with the screening (0% pre-implementation
group; .01% post-implementation group), they were already being followed by ophthalmology
(2% pre-implementation group; 2% post-implementation group), or unknown reasons (0% preimplementation group; 6% post-implementation group) as it was not documented by the nurse
why the visual exam was not performed. Those individuals not screened were documented as
“Null” in the dataset for input into SPSS and documented as “attrition” on final charts and
figures.
No release of information was needed for this EBP project as only chart data were used,
including any referral follow-up information. Parents were not contacted and reminded to followup with ophthalmology if they had not done so by the end of data collection. Nor were parents
contacted to see if they had followed-up with ophthalmology at another facility at the end of data
collection. All pre-implementation referral follow-ups were completed and accounted for. Only
two of the children screened pre-implementation were referred and did follow-up with
ophthalmology. Refractive errors were confirmed on follow-up. Out of the (n = 147) postimplementation group, 16 children were referred to ophthalmology for follow-up. Of the 16
referred to ophthalmology, seven follow-ups were accounted for and refractive errors confirmed.
Of the recruited sample size (N = 322), pre- and post-implementation, 24.8% were 9
months, 30.4% were 24 months, 24.5% 36 months, and 20.2% were 48 months. The majority of
those screened were 24 months of age (see Figure 4.1). Gender and race were also captured
for patients in both the pre- and post-implementation groups for comparison in outcomes (see
Figures 4.2; 4.3).
Age, gender, and race were compared between the two groups. In order to find if there
were differences in results between the pre- and post-implementation group based on age an
independent t-test was performed. The independent t-test found no significant difference (t(2) =
.086, p > .05) in visual abnormalities among age groups pre- and post-implementation. The
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mean for age of the pre-implementation group (M = 2.29, SD = 1.05) was not significantly
different from the mean of the post-implementation group (M = 2.50, SD = 1.07). A chi-square
test of independence was used to compare the frequency of visual abnormalities among
genders and races. Gender was found to have no significance in the outcome of visual

abnormalities (χ2 = .262,a p =>.05). Race was also found to have no significance in frequency
of visual abnormalities (χ2 = 3.622,a p = > .05) between the two groups.
Figure 4.1. Ages Groups
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Figure 4.1. Age group comparisons between pre- and post-implementation samples.
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Figure 4.2. Gender
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Figure 4.2. Gender comparison between pre- and post-implementation samples.

Figure 4.3. Race
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Figure 4.3. Race comparison between Pre and Post-Implementation Samples.
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Changes in Outcomes
Statistical Testing
It was anticipated that each refractive error found with the PlusOptix™ would also be
found with an ophthalmology exam. It was also anticipated that the PlusOptix™ photo screener
would find more refractive errors than traditional pediatric eye exams, without dilatation, during
well-child check-ups within the pediatric clinic. Descriptive frequencies were calculated to
compare the rate of refractive errors found with the PlusOptix™ compared with follow-up
ophthalmology exams. The Chi-Square Goodness of Fit was used to test if the PlusOptix™
photo screener would find more refractive errors than traditional pediatric eye exams. The chisquare test was chosen for its ability to compare observed frequencies to expected frequencies.
This test helps the observer decide if there is a real treatment effect or if observations are just
by chance (Polit & Beck, 2012). The chi-square test was also used to compare frequency of
visual abnormalities among different genders and races. An independent t-test was used to
compare the frequency of visual abnormalities among age groups. The independent t-test was
chosen as it tests the mean of two independent groups to determine if the population means are
significantly different. It tells the observer if there is a difference and if that difference is true or a
random effect (Polit & Beck, 2012). All statistical analyses were performed using IBM® SPSS®
Statistics, version 22.
Significance
The PlusOptix S12™ was implemented in a pediatric clinic in the Midwest. The data
collected post-implementation, using the PlusOptix, ™ were collected over three months and
compared to visual screening data from three months pre-implementation. Data from the
PlusOptix™ were also compared to visual screenings performed at ophthalmology follow-up
screenings to show sensitivity. Specificity could not be calculated as not every child being
screened during their well-child check-up could be sent to ophthalmology to test for absence of
disease. This was due to time and funding constraints. Using Chi-Square (χ2) test, a statistical

62

SCREENING AMBLYOPIC FACTORS 63
significance was found of the PlusOptix™ to identify more refractive errors than the traditional
vision screening performed by the PCP during a well-child check-up (χ2) = 20.430a, p < 0.001).
Of the children (n = 158) screened pre-implementation, two were referred to
ophthalmology. Both children were confirmed to have some sort of refractive error. Of the
children (n = 147) screened post-implementation, 16 children were referred to ophthalmology
but only seven followed-up with ophthalmology (see Figure 4.). All of the seven were confirmed
to have some sort of refractive error, therefore showing the PlusOptix™ as having 100%
sensitivity at identifying visual abnormalities in this sample. Each child in the pre and postimplementation groups passing his/her visual screening was not sent to Ophthalmology to
confirm normal vision results. Therefore, specificity was not obtainable as specificity is the ability
of the test to correctly identify no disease.
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Figure 4.4. Type of Initial Exam Results

Figure 4.4. Type of Initial exam results pre-implementation (pediatrician) and postimplementation (PlusOptix™) showing higher referral rate referral with the PlusOptix™.
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CHAPTER 5
DISCUSSION
This EBP project examined the clinical research question: Will an automated visual
screener detect more refractive errors than traditional visual exams performed by pediatric
providers during routine well child checks. The goal was to implement the PlusOptix S12c™
automated visual photo screeners into the pediatric clinics of a Midwest organization.
Automated visual screeners were supported by the literature to be sensitive for detecting
amblyopic refractive errors. Visual screenings were performed using the PlusOptix S12c™ in
four different age groups (n = 161) during routine well child check-ups. Any “refer” results were
referred to ophthalmology. The pre-implementation group (n = 161, the same number as the
post-implementation group) charts/EHR were randomly chosen from three months prior to
implementation of the PlusOptix™ based on age, well-child check-up, and provider. Both groups
(N = 322) were compared to help show sensitivity and specificity of the PlusOptix™ This
chapter will examine the findings, applicability of the theoretical framework, EBP framework,
strengths and weaknesses of the EBP project, and implications for the future.
Explanation of Findings
The PICOT question asked: “In a pediatric population aged 9 months, 24 months, 36
months, and 48 months, how does early vision screening using an automated photo vision
screener, compared to traditional vision screening techniques affect the number of refractive
errors detected within three months?”
A total of 322 children were recruited in the sample size with 161 children in each the
pre- and post-implementation groups. Three were lost to attrition in the pre-implementation
group (final n = 158) and 14 in the post-implementation group (final n = 147). All preimplementation referral follow-ups were completed and accounted for. Only two of the children
screened pre-implementation were referred and did follow-up with ophthalmology. A refractive
error or errors were confirmed on follow-up. Out of the (n = 147) post-implementation group, 16
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children were referred to ophthalmology for follow-up. Of the 16 referred to ophthalmology,
seven follow-ups were accounted for and refractive errors confirmed.
A chi-square test was used to analyze data to see if the PlusOptix™ would identify more
refractive errors than traditional visual exams performed by the PCP without pupil dilatation. The
chi-square test was also used to look at gender and race in each the pre- and postimplementation groups to see if there was a significant difference among these characteristics.
A t-test was performed to compare frequencies of visual abnormalities among the different age
groups. Sensitivity was also looked at for the PlusOptix™ to compare findings from this EBP
project to the findings within the literature.
Statistical analysis using the chi-square test showed statistical significance of the
PlusOptix™ to identify more refractive errors than the traditional PCP visual exam without the
use of pupil dilatation (χ2 = 20.430a, p < 0.001). The chi-square test showed no statistical
significance in the outcome of visual abnormalities by gender (χ2 = .262,a p = >.05) or race (χ2 =
3.622,a p = > .05). The independent t-test also showed no significant difference in visual
abnormalities detected among age groups pre- (M = 2.29, SD = 1.05) or post-implementation
(M = 2.50, SD = 1.07).
All children failing (n = 16) vision screenings post-implementation (n = 147) using the
PlusOptix™ automated visual screener and that followed-up (n = 7) with ophthalmology were
confirmed to have visual refractive abnormalities. After statistical analysis was performed, the
referral and follow-up rate post-implementation showed the PlusOptix™ to have a sensitivity of
100% and referral rate of 11%. In the pre-implementation group (n = 156), 2 children were
referred to ophthalmology and both followed-up. Both children were confirmed to have a visual
refractive error or errors. After statistical analysis was performed the referral and follow-up rate
for the pre-implementation group, PCP exams were shown to have a referral rate of 1.3%.
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Therefore, showing the PlusOptix™ to have a higher referral rate than provider referrals from
traditional visual exams and a high sensitivity for identifying refractive errors.
Statistical analysis from this EBP project coincides with information found within the
literature. Arnold and Armitage (2014) showed the PlusOptix™ as well as other AVS to have a
sensitivity and specificity greater than 80% at detecting refractive errors. Mu et al. (2016) found
the AVS used in their research to have a sensitivity of 94.79% and specificity of 85%. Singman
et al. (2013) reported the PlusOptix™ to have a sensitivity of 88%, specificity of 87%, and was a
quick, reliable way of screening the pediatric population especially those with autism. Terveen et
al. (2015) showed an 11.9% referral rate using an AVS and no significance difference in
referrals based on gender. Yan et al. (2015) also showed the PlusOptix™ to have sensitivity of
94.9%.
Evaluation of Applicability of Theoretical and EBP Frameworks
Theoretical Framework
The Health Promotion Model (HPM) by Nola J. Pender (Friedman, Bowden, & Jones,
2003; George, 2011) was used as the theoretical framework to help guide this EBP project. The
HPM complements other health protection models to enhance health and well-being. It offers a
process to help motivate individuals to participate in positive behaviors to enhance their health.
Pender’s HPM stresses the importance of self-direction, self-regulation, and perceptions of selfefficacy (Friedman, Bowden, & Jones, 2003; George, 2011). The HPM allows for ease of
applicability by its simplistic stepwise approach
Pender’s HPM focuses on individual characteristics, experiences, behavior-specific
cognitions, and one’s affect and behavioral outcomes. The HPM was appropriate for this EBP
project because the EBP project site prides itself on health promotion and disease prevention.
Pediatric providers highly recommend routine yearly well-child check-ups. Nursing staff help
remind parents of this when in clinic or when a parent or patient calls the clinic to speak with a
nurse. The goal of requiring regular well-child check-ups is to model and promote positive health
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behaviors. This modeling can lead to overall good health maintenance which can last a lifetime
and be passed on to family members. The HPM has a holistic focus based in nursing which
gives it strength by promoting independent practice to provide health promoting interventions
and education to individuals.
Implementation of the AVS was one way the providers and nurses could continue to
promote health and disease prevention. Pender’s HPM suggests if a family perceives a threat
and there are opportunities for decreasing that threat such as health screenings or vision
screenings, the family will be more likely to act on it. In this project, children were being seen for
well-child check-ups and many of them continued to promote health by going to the
ophthalmology clinic based on individual screening results.
EBP Framework
The Stetler Model (SM) provides a stepwise process for gathering sound evidence that
can guide safe and effective care or evidence-based practice. The SM uses a prescriptive
approach, emphasizing critical thinking as a key role. The SM relies on five steps which include:
preparation, validation, comparative evaluation/decision making, translation/application, and
evaluation (Stetler, 2001).
Preparedness entails identifying a need, the environment it involves, organizing, and
initiating evidence research (Ciliska et al., 2011; Stetler, 2001; Young, 2012). It was identified
within the EBP facility there was a need to offer more in depth visual screenings while children
were in for well-child check-ups. This would offer an opportunity to promote health and help
instill the importance of routine visual exams. Eye problems tend to go un-noticed until there are
developmental delays or struggles in school (Bradfield 2013; Forcina et al., 2017; Koning et al.,
2013); USPSTF, 2011).
The validation process requires combing through a body of evidence to select evidence
which best identifies the need for change. For this EBP project, five databases were searched
for best evidence using search terms identified to reveal the best sources. Four-hundred-twenty-
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nine sources were revealed, with some sources overlapping in the different databases. After
reviewing abstracts and relevance, 10 sources were kept for final best practice evidence.
Moving into the next phase is comparative evaluation/decision making. This phase
involves applying a set of criteria to evidence collected in the validation phase to further decide
which evidence best identifies or supports the practice change. Evidence for this EBP project
was appraised and leveled using Melnyk and Fineout-Overholt’s Hierarchy of Evidence and the
Critical Appraisal Skills Programme© (CASP).
Translation/application then occurs requiring conversion of evidence findings into
practice by dissemination, leading to the final phase of evaluation. The translation/application
process for this EBP began with an initial request for implementation being presented to
pediatric providers, the facility administration, and the facility medical board along with evidence
from the literature showing sensitivity and specificity of automated visual screeners. A capital
request form was submitted to the budget committee to request funding for the PlusOptix™
screeners. Approval was granted by the facility medical board to implement the screeners.
Budget was approved to purchase the screeners. Approval was also obtained from the EBP
facility IRB and Valparaiso University IRB to implement the project.
Once approvals were received, formal education was given by the PlusOptix Inc™
representative to the project manager, nursing administration and super users. Education on
use and maintenance of the PlusOptix™ screener via Skype®, PowerPoint®, and online videos
was included. The clinic nursing staff members watched videos from the PlusOptix Inc™
website and performed practice screenings before competency was verified.
A documentation box was created in the electronic health record by a facility IT
representative within the visual screening assessment screen to mark “pass” or “refer” based on
the child’s screening results from the PlusOptix™. If a child received a “refer”, he/she was
referred to ophthalmology onsite for further visual exam to confirm if there was a true refractive
error identified.
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Flowsheets were created by the project manager to collect screening results for pre- and
post-implementation and to de-identify personal health information (PHI). Nursing staff
documented screening results from the PlusOptix™ along with the medical record number and
date of birth on the flowsheets. The project manager used the flowsheets to review the chart,
screening results, and any follow-up ophthalmology results that were obtained. A flowsheet was
also created to document the same information from the pre-implementation group.
Data were collected over three months using the PlusOptix™ screener in the designated
age groups, during well-child check-ups, provided by two of the providers within the Midwest
facility. One-hundred-sixty-one children were identified in the post-implementation group over
the 3 months. Once the post-implementation group number of children was determined to be n
= 161, the same number of patient charts were randomly pulled from EHR by IT, using the
same parameters for age, well-child check-up, and provider as post-implementation. The initial
number of well-child check-ups was unknown. It was anticipated there would be at least 100 in
the sample size. One-hundred-sixty-one check-ups were done during the three months,
therefore, that became the recruitment number for each the pre- and post-implementation
samples.
No release of information was obtained as only chart data were collected. Children were
referred to onsite ophthalmology so the project manager could follow ophthalmology results
through the EHR. No parents were contacted to remind them to follow-up with ophthalmology or
contacted to see if they had followed up with ophthalmology at an outside facility.
Evaluation, the final phase of the SM, involves assessing the new plan of practice to
ensure goals were met, monitor for any adverse occurrences, identify any changes that need to
be made, and how to continue. The evaluation process is a continuous process. The project
manager was easily available on site or via cell phone to help monitor nursing staff to make sure
screenings were being performed appropriately. Lighting and distance parameters had to be
maintained during screenings to assure an accurate screening result by the PlusOptix™. The
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project manager was also available for any trouble shooting, questions with the flowsheets, and
reviewing EHR weekly to make sure screenings were getting documented appropriately.
Strengths and Limitations of the EBP Project
Strengths
Involvement of the providers and administration from the beginning of this EBP project
implementation process was advantageous. Administration was onboard due to evidence from
the literature showing high sensitivity and specificity of AVS. Other facilities within the
community were starting to use AVS and the EBP project facility makes it a priority to stay
abreast of new technologies and what is being used within the local community to help stay
competitive. The EBP facility also prides itself on research which lent a hand to implementation
of this project and support. Providers within the facility were also very interested in the results
that were being obtained from the PlusOptix™ and how it compared to screening methods prior
to its use.
Nursing staff at the EBP project facility was very helpful in the implementation process of
the AVS within the clinic setting. The staff was in frequent communication with the project
manager about how the AVS use in clinic was going.
There were many that helped make this EBP project a success. The IT specialist which
assisted in gathering EHR information was a great help and resource for this EBP project. He
was able to capture EHR that fit the parameters of the project so the project manager could
gather pre-implementation data. He also helped retrieve EHR for the post-implementation group
so the project could start on time at the beginning of October. Facility IRB was not approved to
collect data on the EBP project until the beginning of November. The facility IRB and Valparaiso
IRB gave approval to collect data from the EHR dating back to the beginning of October when
the AVS were first being used.
Assistance was received from the director of research at the EBP project site and with a
statistician consult on the use of SPSS and data results.
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Parents bringing their children in for a well-child check-up in the specified age groups for
screenings were very receptive and even intrigued by the use of an AVS. Parents were
informed and educated on the use of the PlusOptix™ and different refractive errors it could
detect.
Visual screenings were faster and easier for nursing staff to perform using the PlusOptix.
Children were very cooperative with the visual screenings due to a picture on the machine, the
“warble” sound it makes, the quickness of the screening, and that the child was not confined
during the screening.
The PlusOptix Inc™ representative for the area where the EBP facility was located was
very helpful and readily available via email. She provided the initial education on the
PlusOptix™, its use, trouble shooting, results interpretation, and maintenance. She was
available to the project manager to educate on how to perform calculations using the results
from the PlusOptix™ in order to see why the child was being referred to ophthalmology.
Limitations
Limitations to this EBP project included incomplete documentation by nursing staff for
several children which resulted in no screening results. The screening technique/routine was
new for the nursing staff and documentation within the EHR changed from the previous
processes. Having a float nurse from another clinic or prn staff that was not aware of the data
collection system also contributed to no screening results. All regular nursing staff at the EBP
facility were aware of the data collection and were trained in the use of the flowsheets and
which provider patient population was being used. However, prn staff and staff from the other
five facilities were not aware of the data collection process. If the project manager was not
onsite the day prn staff or staff from another clinic worked, they were not always made of aware
of the data collection process on the flow sheets. In the future, prn staff and any float staff could
be given a folder with the data collection information to help decrease missed screening
documentation on flow sheets.
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Not all children completed follow-up with ophthalmology to further support sensitivity of
the PlusOptix™ or contribute to specificity results. No release of information was obtained from
those being screened and only chart data were collected. Therefore, parents were not contacted
and reminded to follow-up with ophthalmology or to check if they had followed-up with
ophthalmology at an outside facility. When performing a project like this in the future, the project
manager would recommend release of information be obtained when implementing the project.
Then parents could be contacted to encourage follow-up appointments with ophthalmology
referrals leading to more data to further confirm sensitivity of the PlusOptix.
Specificity was not obtainable for this EBP project as not all children who completed the
visual screening were sent to ophthalmology to confirm the absence of disease. This situation
was due to time and funding limitations. However, there were data within the literature to show
high specificity of AVS. A time-frame of three months was implemented for this EBP project and
there was no funding to cover ophthalmology screenings without a referring diagnosis.
Implications for the Future
Practice
The USPSTF reports 1% to 5% of U.S preschool aged children have some sort of visual
impairment (USPSTF 2011), and the AAP, AAPOS, AAO, and AACO (2003) recommend visual
screenings starting in newborns then with every well-child check-up visit thereafter. It is
important for advanced practice registered nurses (APRN), as well as all providers, to stay
abreast of new research regarding health promotion and illness prevention such as visual
screenings. By implementing the most up to date recommendations, APRN’s are able to offer
the best care and information to help mitigate chronic diseases.
It is important for APRN’s and nurses to develop a strategy to communicate with parents
regarding the importance of health maintenance, such as regular visual screenings and followup with ophthalmology for any abnormal findings. This will help aid in health promotion.
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Automated visual screeners, such as the PlusOptix™ have greater sensitivity and referral rates
than visual screenings performed by providers alone during a well-child check-up. Therefore,
AVS should be considered for implementation in pre-school age children screenings performed
by nursing staff during well-child check-ups and in many different settings
Theory
The Health Promotion Model (HPM) postulates that specific behaviors and cognitions
are directly related to individual health promotion behaviors (Friedman, Bowden, & Jones,
2003). An individual’s prior behavior as well as inherited and acquired characteristics have great
impact on the individual’s prior behavior. The inherited and acquired characteristics have a great
impact on the individual’s beliefs, affect, and how the individual views health promoting
behaviors. The pre-school age group is not yet able to have their own views about health
promoting behaviors, but by teaching parents these behaviors they can be passed down to their
children. Therefore, it is important to create positive affects in the individual’s beliefs and health
promotion behaviors to pass down to future generations.
The HPM allows for ease of applicability by its simplistic stepwise approach and was
intended for any individual in any situation other than the illness state. These features of the
HPM make it very adaptable in the health promotion, disease prevention setting, and a good
model for APN’s and nurses to follow when implementing new screening techniques such as
AVS. If a family perceives a threat and there are opportunities for decreasing that threat, such
as vision screenings, the family will be more likely to act on it. When providing information,
parents will be able to actively own the behavior of early vision screening.
Research
Further research and education is needed to continue to show sensitivity and specificity
of AVS and then be disseminated to primary providers. Research with funding is needed so all
those within the recruited population can be screened both with an AVS and then with
ophthalmology to show those confirmed to have disease (sensitivity) and those without disease
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(specificity). More research is needed in a variety of settings using AVS to better show their
ability to be effective at detecting refractive errors, especially in the very young preschool ages.
Education
Continued education is needed for APN’s, nurses, and all healthcare providers on the
importance of early vision screening as recommended by the USPSTF and other organizations.
In order to get this education out there, continued research with its results and projects such as
this EBP project need to be published and disseminated to all providers and facilities who
provide visual screenings. AVS are reliable, easy to use, highly sensitive pieces of equipment
that should be available in many different settings. Dissemination of information can include
research conferences, nursing conferences, advanced practice conferences, and manuscript
publishing of findings. Also, organizations such as the Lion’s Club, who advocate for good vision
programs and help with vision screenings in many communities, are a good resource to help in
purchasing AVS. AVS are expensive but there are many organizations that are willing to help
with various health promotion activities, such as screenings, to help gather funding for new
screening equipment. It is important for APRN’s and nurses to continue to educate the
communities in which they serve about the importance of wellness and health promotion. By
attending yearly well exams, chronic disease can be diminished and better outcomes
accomplished. APRN’s and nurses also need to continue their own education by staying abreast
of new research being done and printed in the literature and also by attending conferences with
up-to-date information. Being informed better prepares APN’s and nurses to promote health and
wellness to their community.
Conclusion
In conclusion, the goal of this EBP project was to implement an AVS, the PlusOptix™, in
a Midwest pediatric clinic for visual screenings as AVS were shown in the literature to have high
sensitivity and specificity to detect refractive errors. Findings from this EBP project
demonstrated that AVS can statistically improve the detection rate of refractive errors in 9-
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month, 24-month, 36-month, and 48-month-old children. Data showed a referral rate of 1.3% in
the pre-implementation group. A referral rate of 11.3% was revealed in the post-implementation
group with a sensitivity of 100%. Findings from this EBP project were similar to that reported in
the literature and answered the PICOT question: will an automated visual screener detect more
refractive errors than traditional visual exams performed by pediatric providers during routine
well-child checks. The Plusoptix™ found more refractive errors than traditional visual exams in
this pediatric population. Thus, primary care providers should consider implementing AVS into
their routine well-child check-ups for young children who are pre-verbal and those populations
with behavioral or developmental disabilities, as they are a great asset to detect and mitigate
visual abnormalities.
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ACRONYM LIST
AACO: American Association of Certified Orthoptists
AAO: American Academy of Ophthalmology
AAP: American Academy of Pediatrics
AAPOS: American Association of Pediatric Ophthalmology and Strabismus
ADHD: Attention Deficit Hyperactivity Disorder
AVS: Automated Visual Screener(s)
CASP: Critical Appraisal Skills Programme
CINAHL: Cumulative Index of Nursing and Allied Health Literature
DNP: Doctorate of Nursing Practice
EBP: Evidence Based Practice
EHR: Electronic Health Record
EPC: Oregon Evidence-based Practice Center
HPM: Health Promotion Model
IDN: Identification Number
PCP: Primary Care Provider(s)
PHI: Protected Health Information
PPV: Positive Predictive Value
SM: Stetler Model
USPSTF: US Preventive Services Task Force
WCC: Well Child Check(s)
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APPENDIX A
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APPENDIX B

Quick reference guide - Vision Screener plusoptiX S12C
Thank you for choosing plusoptiX S12C. An award winning, 4th generation vision screening device. This quick
reference guide will support you in performing your first vision screening in 8 easy steps:

Ensure that the batteries are inserted with the
proper orientation. Follow the guide in the
battery compartment. Then close the lid. Press
On/Off button to switch device on.

Choose date and time format by touching the
appropriate buttons on screen. Then set date
and time using the arrow buttons. Confirm with
green checkmark button to proceed to start
screen. Select age group of patient by touching
appropriate button on screen.

The patient needs to fixate on camera lens. Level
camera to patient’s eyes and press shutter to see
camera picture on screen.
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Tilt camera so that screen is inclined by
45 degrees. Avoid sunlight and
distractions. Adjust room light to
obtain proper pupil size of 4 to 8mm.

Identify
right measurement distance by observing camera picture on
screen. Start at 4 feet. Camera picture is blurred. Move closer
until picture is in clear focus. A warble sound is being played
and measurement starts automatically.
Distance too far: Pupils crowded in white squares
Right distance: Pupils circled in green
Distance too close: Pupils almost do not fit onto screen

Step 6
A ping sound is played at the end of a
measurement. Camera picture freezes and a
green “pass” or red “refer” screening result is
shown on screen. Use orange arrow buttons to
toggle in between result screens.

Step 7
A “pass” vision screening result indicates that all readings are
below the referral thresholds, i.e. are in normal range.
In some cases an error message will be displayed on screen. In this case vision screening
result is inconclusive. Review user manual for hints on how to avoid an aborted
measurement and retry. If error message reads “measurement incomplete” in two
consecutive attempts, vision screening result is deemed to be “refer”.
A “refer” vision screening result indicates that
one or more readings are at or above referral
thresholds. These patients need to be sent to an
eye care professional
for a comprehensive eye exam. Pass Picture out
Refer of focus
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Step 8
In settings you will find five validated sets of referral
thresholds to choose from. They range from very
sensitive (and less specific) to very specific
Access

Access referral

(and less sensitive). settings threshold settings
Pay attention to the description provided on screen
and access on screen help to review referral
thresholds in detail.

Please note:
Children with glasses are already under the care of an eye care professional and therefore need not be screened. If your program requires
screening of children with glasses then the child should be screened wearing the glasses and the glasses should be tilted up at the temples to
reduce glare.
Plusoptix devices are specifically designed for the purpose of detecting the most common vision disorders in toddlers and preschool children.
The screening of adults is only valid to identify the possibility of refractive error (need for glasses). Adults should receive comprehensive eye
examinations to detect early stages of age related eye diseases. The methods used for children’s screening are not able to detect adult
eye/vision diseases.
These steps as well as all other features of your device are explained in detail in the user manual. The
user manual describes error messages and fixes in detail, too. In case you don’t have a copy of the user
manual, you can download it here:
www.plusoptix.com/images/plusoptix/doku/usermanualS12USA.pdf
Once the device is switched on, you have access to additional information by
touching the blue “i” icon located at the bottom right corner of each screen. This
button opens an on screen help page.
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APPENDIX C
Post-Implementation Data Flow Sheet

Medical Record
Number

Date of Birth

PlusOptix Results

ID Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
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APPENDIX D
De-identified Post-Implementation Flow Sheet

ID
Number

Date of Birth

PlusOptix
Results

89

Ophthalmology
Results
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APPENDIX E
Pre-Implementation Data Flow Sheet

Medical Record
Number

Date of Birth

Traditional
Screening
(preimplementation)

ID Number

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
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APPENDIX F
De-Identified Pre-Implementation Data Flow Sheet

ID
Number

Date of Birth

Traditional
Results

91

Ophthalmology
Results
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